> top > docs > PMC:1064873 > spans > 19723-21332 > annotations

PMC:1064873 / 19723-21332 JSONTXT

Annnotations TAB JSON ListView MergeView

LappsTest

Id Subject Object Predicate Lexical cue
T17298 1566-1571 Protein denotes STAT1
T17297 1526-1531 Protein denotes STAT3
T17296 1492-1497 Protein denotes STAT1
T17295 1467-1471 Protein denotes IL-6
T17294 1394-1399 Protein denotes STAT1
T17293 1308-1340 Protein denotes dominant STAT3-activating factor
T17292 1296-1300 Protein denotes IL-6
T17291 1243-1247 Protein denotes IL-6
T17290 1184-1189 Protein denotes STAT3
T17289 1168-1173 Protein denotes STAT1
T17288 1154-1159 Protein denotes STAT3
T17287 1038-1042 Protein denotes STAT
T17286 981-1012 Protein denotes neutralizing anti-IL-6 antibody
T17285 868-872 Protein denotes CD4+
T17284 785-789 Protein denotes CD4+
T17283 770-774 Protein denotes IL-6
T17282 731-736 Protein denotes STAT3
T17281 721-726 Protein denotes STAT1
T17280 685-690 Protein denotes IL-10
T17279 650-655 Protein denotes STAT3
T17278 584-588 Protein denotes IL-6
T17277 545-549 Protein denotes CD4+
T17276 410-414 Protein denotes IL-6
T17275 371-376 Protein denotes STAT3
T17274 285-289 Protein denotes IL-6
T17273 190-213 Protein denotes epidermal growth factor
T17272 154-184 Protein denotes platelet-derived growth factor
T17271 94-98 Protein denotes IL-6
T17270 68-79 Protein denotes IL-6 family
T17269 0-5 Protein denotes STAT3

2_test

Id Subject Object Predicate Lexical cue
15535835-12039028-4156895 237-238 12039028 denotes 4
15535835-7869026-4156896 399-401 7869026 denotes 31
15535835-9182920-4156897 497-499 9182920 denotes 27
15535835-12039028-4156898 857-858 12039028 denotes 4

biosemtest

Id Subject Object Predicate Lexical cue
T18007 1179-1183 UMLS/C0323983 denotes this
T18006 73-79 UMLS/C1704727 denotes family
T18000 522-532 UMLS/C0205322 denotes persistent
T17999 1016-1023 UMLS/C2587213 denotes control
T17997 1442-1448 UMLS/C1299351 denotes higher
T17996 561-565 UMLS/C1299351 denotes high
T17994 671-681 UMLS/C0237834 denotes resistance
T17990 490-495 UMLS/C0439275 denotes ng/ml
T17989 1024-1032 UMLS/C0003241 denotes antibody
T17988 1004-1012 UMLS/C0003241 denotes antibody
T17986 861-867 UMLS/C0205307 denotes Normal
T17985 778-784 UMLS/C0205307 denotes normal
T17983 1386-1390 UMLS/C0332268 denotes lack
T17981 1582-1585 UMLS/C0337876 denotes may
T17980 1472-1475 UMLS/C0337876 denotes may
T17976 1341-1350 UMLS/C0332256 denotes contained
T17975 932-942 UMLS/C0332256 denotes containing
T17974 1274-1281 UMLS/C1546471 denotes results
T17973 73-79 UMLS/C1555907 denotes family
T17971 1603-1608 UMLS/C1151254 denotes serum
T17970 1417-1422 UMLS/C1151254 denotes serum
T17969 1354-1358 UMLS/C1151254 denotes sera
T17968 1101-1106 UMLS/C1151254 denotes serum
T17967 947-952 UMLS/C1151254 denotes serum
T17966 435-439 UMLS/C1151254 denotes sera
T17965 917-931 UMLS/C0010454 denotes culture medium
T17961 1164-1167 UMLS/C1518422 denotes not
T17960 804-807 UMLS/C1518422 denotes not
T17959 100-105 UMLS/C0537670 denotes IL-11
T17958 908-911 UMLS/C0439232 denotes min
T17957 1016-1023 UMLS/C0332298 denotes control
T17956 1372-1380 UMLS/C1705908 denotes patients
T17955 968-976 UMLS/C1705908 denotes patients
T17954 453-461 UMLS/C1705908 denotes patients
T17953 1341-1350 UMLS/C2700400 denotes contained
T17952 932-942 UMLS/C2700400 denotes containing
T17950 1119-1125 UMLS/C0205263 denotes induce
T17949 336-343 UMLS/C0205263 denotes induces
T17948 218-229 UMLS/C0332287 denotes addition to
T17942 1572-1581 UMLS/C1710082 denotes signaling
T17941 1341-1350 UMLS/C1549781 denotes contained
T17940 932-942 UMLS/C1549781 denotes containing
T17939 1038-1042 UMLS/C1366753 denotes STAT
T17938 1225-1239 UMLS/C1446680 denotes neutralization
T17937 474-482 UMLS/C0442726 denotes detected
T17936 73-79 UMLS/C1552262 denotes family
T17934 861-867 UMLS/C2347086 denotes Normal
T17933 778-784 UMLS/C2347086 denotes normal
T17930 1449-1463 UMLS/C0086045 denotes concentrations
T17929 566-580 UMLS/C0086045 denotes concentrations
T17928 1225-1239 UMLS/C1578828 denotes neutralization
T17927 819-828 UMLS/C0680240 denotes agreement
T17926 1589-1596 UMLS/C0449450 denotes present
T17923 691-701 UMLS/C1628982 denotes inhibition
T17922 254-261 UMLS/C1705923 denotes studies
T17921 640-649 UMLS/C0443318 denotes sustained
T17918 1526-1531 UMLS/C1367307 denotes STAT3
T17917 1317-1322 UMLS/C1367307 denotes STAT3
T17916 1184-1189 UMLS/C1367307 denotes STAT3
T17915 1154-1159 UMLS/C1367307 denotes STAT3
T17914 731-736 UMLS/C1367307 denotes STAT3
T17913 650-655 UMLS/C1367307 denotes STAT3
T17912 371-376 UMLS/C1367307 denotes STAT3
T17911 0-5 UMLS/C1367307 denotes STAT3
T17909 843-855 UMLS/C0700325 denotes observations
T17907 861-867 UMLS/C0439166 denotes Normal
T17906 778-784 UMLS/C0439166 denotes normal
T17904 190-213 UMLS/C1749410 denotes epidermal growth factor
T17903 1248-1256 UMLS/C0439167 denotes activity
T17902 1016-1023 UMLS/C0243148 denotes control
T17901 1479-1487 UMLS/C1514873 denotes required
T17900 799-803 UMLS/C1511726 denotes data
T17899 107-133 UP/P09056 denotes leukemia inhibitory factor
T17898 107-133 UP/P15018 denotes leukemia inhibitory factor
T17895 73-79 UMLS/C2700055 denotes family
T17894 1566-1571 UP/P42224 denotes STAT1
T17893 1492-1497 UP/P42224 denotes STAT1
T17892 1394-1399 UP/P42224 denotes STAT1
T17891 1168-1173 UP/P42224 denotes STAT1
T17890 721-726 UP/P42224 denotes STAT1
T17889 843-855 UMLS/C0302523 denotes observations
T17888 596-613 UMLS/C0005775 denotes blood circulation
T17886 1603-1608 UMLS/C1550100 denotes serum
T17885 1417-1422 UMLS/C1550100 denotes serum
T17884 1354-1358 UMLS/C1550100 denotes sera
T17883 1101-1106 UMLS/C1550100 denotes serum
T17882 947-952 UMLS/C1550100 denotes serum
T17881 435-439 UMLS/C1550100 denotes sera
T17880 1126-1150 UMLS/C1519726 denotes tyrosine phosphorylation
T17879 1572-1581 UMLS/C0037083 denotes signaling
T17877 1225-1239 UMLS/C1550107 denotes neutralization
T17872 1372-1380 UMLS/C1550655 denotes patients
T17871 968-976 UMLS/C1550655 denotes patients
T17870 453-461 UMLS/C1550655 denotes patients
T17869 891-900 UMLS/C1439852 denotes incubated
T17868 41-55 UP/Q776B5 denotes growth factors
T17866 41-55 UP/Q86607 denotes growth factors
T17864 1016-1023 UMLS/C1547100 denotes control
T17861 1526-1531 UMLS/C0253050 denotes STAT3
T17860 1317-1322 UMLS/C0253050 denotes STAT3
T17859 1184-1189 UMLS/C0253050 denotes STAT3
T17858 1154-1159 UMLS/C0253050 denotes STAT3
T17857 731-736 UMLS/C0253050 denotes STAT3
T17856 650-655 UMLS/C0253050 denotes STAT3
T17855 371-376 UMLS/C0253050 denotes STAT3
T17854 0-5 UMLS/C0253050 denotes STAT3
T17852 41-55 UP/Q8V307 denotes growth factors
T17850 1442-1448 UMLS/C1522410 denotes higher
T17849 561-565 UMLS/C1522410 denotes high
T17848 107-133 UP/P17777 denotes leukemia inhibitory factor
T17845 107-133 UMLS/C1761537 denotes leukemia inhibitory factor
T17844 316-330 UMLS/C0039097 denotes synovial fluid
T17841 861-867 UMLS/C1873497 denotes Normal
T17840 778-784 UMLS/C1873497 denotes normal
T17837 522-532 UMLS/C0546816 denotes persistent
T17836 1248-1256 UMLS/C0441655 denotes activity
T17834 691-701 UMLS/C0021467 denotes inhibition
T17830 691-701 UMLS/C0021469 denotes inhibition
T17829 154-184 UMLS/C1761525 denotes platelet-derived growth factor
T17827 1589-1596 UMLS/C0150312 denotes present
T17826 1437-1441 UMLS/C0439064 denotes much
T17825 22-26 UMLS/C0439064 denotes many
T17823 1024-1032 UMLS/C1621287 denotes antibody
T17822 1004-1012 UMLS/C1621287 denotes antibody
T17820 1258-1261 UMLS/C0349966 denotes Fig
T17819 1362-1368 UMLS/C1553875 denotes active
T17818 958-964 UMLS/C1553875 denotes active
T17817 705-711 UMLS/C1553875 denotes active
T17816 443-449 UMLS/C1553875 denotes active
T17813 254-261 UMLS/C0557651 denotes studies
T17809 873-880 UMLS/C0039194 denotes T cells
T17808 790-797 UMLS/C0039194 denotes T cells
T17807 550-557 UMLS/C0039194 denotes T cells
T17805 139-151 UMLS/C1335093 denotes oncostatin M
T17803 139-151 UMLS/C0069535 denotes oncostatin M
T17799 41-55 UP/P08441 denotes growth factors
T17795 1512-1520 UMLS/C1707455 denotes compared
T17794 154-184 UMLS/C0032200 denotes platelet-derived growth factor
T17793 1016-1023 UMLS/C1550141 denotes control
T17791 1603-1608 UMLS/C0229671 denotes serum
T17790 1417-1422 UMLS/C0229671 denotes serum
T17789 1354-1358 UMLS/C0229671 denotes sera
T17788 1101-1106 UMLS/C0229671 denotes serum
T17787 947-952 UMLS/C0229671 denotes serum
T17786 435-439 UMLS/C0229671 denotes sera
T17784 1449-1463 UMLS/C1446561 denotes concentrations
T17783 566-580 UMLS/C1446561 denotes concentrations
T17782 1038-1042 UMLS/C1548425 denotes STAT
T17781 100-105 UMLS/C1149216 denotes IL-11
T17775 685-690 UMLS/C1149215 denotes IL-10
T17774 230-235 UMLS/C1149215 denotes IL-10
T17771 1603-1608 UMLS/C1546774 denotes serum
T17770 1417-1422 UMLS/C1546774 denotes serum
T17769 1354-1358 UMLS/C1546774 denotes sera
T17768 1101-1106 UMLS/C1546774 denotes serum
T17767 947-952 UMLS/C1546774 denotes serum
T17766 435-439 UMLS/C1546774 denotes sera
T17762 671-681 UMLS/C1522618 denotes resistance
T17761 843-855 UMLS/C1554188 denotes observations
T17760 908-911 UMLS/C1552937 denotes min
T17753 1467-1471 UMLS/C1149241 denotes IL-6
T17752 1296-1300 UMLS/C1149241 denotes IL-6
T17751 1243-1247 UMLS/C1149241 denotes IL-6
T17750 770-774 UMLS/C1149241 denotes IL-6
T17749 584-588 UMLS/C1149241 denotes IL-6
T17748 410-414 UMLS/C1149241 denotes IL-6
T17747 285-289 UMLS/C1149241 denotes IL-6
T17746 94-98 UMLS/C1149241 denotes IL-6
T17745 68-72 UMLS/C1149241 denotes IL-6
T17743 1566-1571 UMLS/C1335872 denotes STAT1
T17742 1492-1497 UMLS/C1335872 denotes STAT1
T17741 1394-1399 UMLS/C1335872 denotes STAT1
T17740 1168-1173 UMLS/C1335872 denotes STAT1
T17739 721-726 UMLS/C1335872 denotes STAT1
T17737 1582-1585 UMLS/C0454788 denotes may
T17736 1472-1475 UMLS/C0454788 denotes may
T17732 1552-1562 UMLS/C1999216 denotes inhibitors
T17731 474-482 UMLS/C1511790 denotes detected
T17729 1532-1542 UMLS/C1879547 denotes activation
T17728 1498-1508 UMLS/C1879547 denotes activation
T17727 1400-1410 UMLS/C1879547 denotes activation
T17664 1442-1448 UMLS/C1561957 denotes higher
T17663 561-565 UMLS/C1561957 denotes high
T17661 1442-1448 UMLS/C1561958 denotes higher
T17660 561-565 UMLS/C1561958 denotes high
T17654 1467-1471 UMLS/C0021760 denotes IL-6
T17653 1296-1300 UMLS/C0021760 denotes IL-6
T17652 1243-1247 UMLS/C0021760 denotes IL-6
T17651 770-774 UMLS/C0021760 denotes IL-6
T17650 584-588 UMLS/C0021760 denotes IL-6
T17649 410-414 UMLS/C0021760 denotes IL-6
T17648 285-289 UMLS/C0021760 denotes IL-6
T17647 94-98 UMLS/C0021760 denotes IL-6
T17646 68-72 UMLS/C0021760 denotes IL-6
T17644 1075-1096 UMLS/C0949466 denotes western blot analysis
T17643 1308-1316 UMLS/C1527180 denotes dominant
T17642 1372-1380 UMLS/C0030705 denotes patients
T17641 968-976 UMLS/C0030705 denotes patients
T17640 453-461 UMLS/C0030705 denotes patients
T17633 1467-1471 UMLS/C1334122 denotes IL-6
T17632 1296-1300 UMLS/C1334122 denotes IL-6
T17631 1243-1247 UMLS/C1334122 denotes IL-6
T17630 770-774 UMLS/C1334122 denotes IL-6
T17629 584-588 UMLS/C1334122 denotes IL-6
T17628 410-414 UMLS/C1334122 denotes IL-6
T17627 285-289 UMLS/C1334122 denotes IL-6
T17626 94-98 UMLS/C1334122 denotes IL-6
T17625 68-72 UMLS/C1334122 denotes IL-6
T17623 1038-1042 UMLS/C1335960 denotes STAT
T17622 1479-1487 UMLS/C1556066 denotes required
T17621 1111-1115 UMLS/C1299581 denotes able
T17620 1372-1380 UMLS/C1578479 denotes patients
T17619 968-976 UMLS/C1578479 denotes patients
T17618 453-461 UMLS/C1578479 denotes patients
T17617 1038-1042 UMLS/C1420304 denotes STAT
T17616 1248-1256 UMLS/C1561536 denotes activity
T17615 1372-1380 UMLS/C1578483 denotes patients
T17614 968-976 UMLS/C1578483 denotes patients
T17613 453-461 UMLS/C1578483 denotes patients
T17612 1372-1380 UMLS/C1578480 denotes patients
T17611 968-976 UMLS/C1578480 denotes patients
T17610 453-461 UMLS/C1578480 denotes patients
T17609 1372-1380 UMLS/C1578481 denotes patients
T17608 968-976 UMLS/C1578481 denotes patients
T17607 453-461 UMLS/C1578481 denotes patients
T17606 1372-1380 UMLS/C1578486 denotes patients
T17605 968-976 UMLS/C1578486 denotes patients
T17604 453-461 UMLS/C1578486 denotes patients
T17602 1372-1380 UMLS/C1578484 denotes patients
T17601 968-976 UMLS/C1578484 denotes patients
T17600 453-461 UMLS/C1578484 denotes patients
T17599 1372-1380 UMLS/C1578485 denotes patients
T17598 968-976 UMLS/C1578485 denotes patients
T17597 453-461 UMLS/C1578485 denotes patients
T17596 1024-1032 UMLS/C0021027 denotes antibody
T17595 1004-1012 UMLS/C0021027 denotes antibody
T17594 41-55 UP/Q6RZT5 denotes growth factors
T17592 1566-1571 UP/P42229 denotes STAT1
T17591 1492-1497 UP/P42229 denotes STAT1
T17590 1394-1399 UP/P42229 denotes STAT1
T17589 1168-1173 UP/P42229 denotes STAT1
T17588 721-726 UP/P42229 denotes STAT1
T17587 100-105 UMLS/C0083031 denotes IL-11
T17586 1362-1368 UMLS/C1561511 denotes active
T17585 958-964 UMLS/C1561511 denotes active
T17584 705-711 UMLS/C1561511 denotes active
T17583 443-449 UMLS/C1561511 denotes active
T17582 1552-1562 UMLS/C0243077 denotes inhibitors
T17581 1362-1368 UMLS/C1561512 denotes active
T17580 958-964 UMLS/C1561512 denotes active
T17579 705-711 UMLS/C1561512 denotes active
T17578 443-449 UMLS/C1561512 denotes active
T17577 1362-1368 UMLS/C1561513 denotes active
T17576 958-964 UMLS/C1561513 denotes active
T17575 705-711 UMLS/C1561513 denotes active
T17574 443-449 UMLS/C1561513 denotes active
T17572 1282-1290 UMLS/C1444656 denotes indicate
T17571 41-55 UP/P20494 denotes growth factors
T17570 533-541 UMLS/C1704625 denotes exposure
T17569 463-473 UMLS/C0332183 denotes frequently
T17568 834-842 UMLS/C0205156 denotes previous
T17567 245-253 UMLS/C0205156 denotes previous
T17566 107-133 UMLS/C0125606 denotes leukemia inhibitory factor
T17564 297-302 UMLS/C0205164 denotes major
T17563 107-133 UP/Q27956 denotes leukemia inhibitory factor
T17562 1479-1487 UMLS/C1546857 denotes required
T17561 843-855 UMLS/C1548358 denotes observations
T17559 533-541 UMLS/C0332157 denotes exposure
T17558 533-541 UMLS/C0274281 denotes exposure
T17557 254-261 UMLS/C1880229 denotes studies
T17556 380-397 UMLS/C0806987 denotes mononuclear cells
T17555 1362-1368 UMLS/C0205177 denotes active
T17554 958-964 UMLS/C0205177 denotes active
T17553 705-711 UMLS/C0205177 denotes active
T17552 443-449 UMLS/C0205177 denotes active
T17551 107-133 UP/O62728 denotes leukemia inhibitory factor
T17550 843-855 UMLS/C0557985 denotes observations
T17548 671-681 UMLS/C0683598 denotes resistance
T17547 1362-1368 UMLS/C2347179 denotes active
T17546 958-964 UMLS/C2347179 denotes active
T17545 705-711 UMLS/C2347179 denotes active
T17544 443-449 UMLS/C2347179 denotes active
T17543 1263-1265 UMLS/C1553637 denotes 5a
T17537 685-690 UMLS/C0085295 denotes IL-10
T17536 230-235 UMLS/C0085295 denotes IL-10
T17534 843-855 UMLS/C1964257 denotes observations
T17531 1423-1431 UMLS/C1705535 denotes suggests
T17530 41-55 UP/O57166 denotes growth factors
T17528 861-867 UMLS/C1704701 denotes Normal
T17527 778-784 UMLS/C1704701 denotes normal
T17525 41-55 UMLS/C0018284 denotes growth factors
T17524 1160-1163 UMLS/C0005341 denotes but
T17523 241-244 UMLS/C0005341 denotes but
T17519 1116-1118 UMLS/C0319022 denotes to
T17518 682-684 UMLS/C0319022 denotes to
T17517 558-560 UMLS/C0319022 denotes to
T17510 1063-1071 UMLS/C0332128 denotes examined
T17509 505-513 UMLS/C0332128 denotes examined
T17508 423-431 UMLS/C2346714 denotes abundant
T17507 190-213 UMLS/C0242275 denotes epidermal growth factor
T17506 171-199 UMLS/C0242275 denotes growth factor, and epidermal
T17504 861-867 UMLS/C1550457 denotes Normal
T17503 778-784 UMLS/C1550457 denotes normal
T17501 41-55 UP/P08072 denotes growth factors
T17500 843-855 UMLS/C0941132 denotes observations
T17499 1479-1487 UMLS/C1619636 denotes required
T17498 1362-1368 UMLS/C1561510 denotes active
T17497 958-964 UMLS/C1561510 denotes active
T17496 705-711 UMLS/C1561510 denotes active
T17495 443-449 UMLS/C1561510 denotes active
T17494 41-55 UP/P33804 denotes growth factors
T17493 1362-1368 UMLS/C1561509 denotes active
T17492 958-964 UMLS/C1561509 denotes active
T17491 705-711 UMLS/C1561509 denotes active
T17490 443-449 UMLS/C1561509 denotes active
T17489 1362-1368 UMLS/C1561508 denotes active
T17488 958-964 UMLS/C1561508 denotes active
T17487 705-711 UMLS/C1561508 denotes active
T17486 443-449 UMLS/C1561508 denotes active
T17485 1362-1368 UMLS/C1561507 denotes active
T17484 958-964 UMLS/C1561507 denotes active
T17483 705-711 UMLS/C1561507 denotes active
T17482 443-449 UMLS/C1561507 denotes active
T17481 254-261 UMLS/C0947630 denotes studies
T17946 1442-1448 UMLS/C0205250 denotes higher
T17945 561-565 UMLS/C0205250 denotes high
T17944 1274-1281 UMLS/C0332294 denotes results
T17943 1274-1281 UMLS/C1274040 denotes results
T17480 1043-1058 UMLS/C0031715 denotes phosphorylation
T17479 737-752 UMLS/C0031715 denotes phosphorylation
T17478 73-79 UMLS/C1563343 denotes family
T17476 861-867 UMLS/C1551394 denotes Normal
T17475 778-784 UMLS/C1551394 denotes normal
T17473 1362-1368 UMLS/C1547419 denotes active
T17472 958-964 UMLS/C1547419 denotes active
T17471 705-711 UMLS/C1547419 denotes active
T17470 443-449 UMLS/C1547419 denotes active
T17469 83-92 UMLS/C0079189 denotes cytokines
T17468 27-36 UMLS/C0079189 denotes cytokines
T17467 41-55 UP/Q9JFH4 denotes growth factors
T17466 1016-1023 UMLS/C1882979 denotes control
T17465 834-842 UMLS/C1552607 denotes previous
T17464 245-253 UMLS/C1552607 denotes previous
T17726 1323-1333 UMLS/C1879547 denotes activating
T17725 1190-1200 UMLS/C1879547 denotes activation
T17724 757-766 UMLS/C1879547 denotes activated
T17723 656-666 UMLS/C1879547 denotes activation
T17722 357-367 UMLS/C1879547 denotes activation
T17721 9-18 UMLS/C1879547 denotes activated
T17720 1274-1281 UMLS/C1280519 denotes results
T17719 73-79 UMLS/C0015576 denotes family
T17718 254-261 UMLS/C0008972 denotes studies
T17717 1111-1115 UMLS/C0085732 denotes able
T17716 254-261 UMLS/C0008976 denotes studies
T17710 1467-1471 UMLS/C1527132 denotes IL-6
T17709 1296-1300 UMLS/C1527132 denotes IL-6
T17708 1243-1247 UMLS/C1527132 denotes IL-6
T17707 770-774 UMLS/C1527132 denotes IL-6
T17706 584-588 UMLS/C1527132 denotes IL-6
T17705 410-414 UMLS/C1527132 denotes IL-6
T17704 285-289 UMLS/C1527132 denotes IL-6
T17703 94-98 UMLS/C1527132 denotes IL-6
T17702 68-72 UMLS/C1527132 denotes IL-6
T17697 100-105 UMLS/C1334100 denotes IL-11
T17696 908-911 UMLS/C0702093 denotes min
T17694 1038-1042 UMLS/C0205548 denotes STAT
T17693 618-629 UMLS/C1273518 denotes responsible
T17687 685-690 UMLS/C1522550 denotes IL-10
T17686 230-235 UMLS/C1522550 denotes IL-10
T17677 685-690 UMLS/C1334098 denotes IL-10
T17676 230-235 UMLS/C1334098 denotes IL-10
T17674 41-55 UP/P01136 denotes growth factors
T17672 254-261 UMLS/C2603343 denotes studies
T17671 1016-1023 UMLS/C0009932 denotes control
T17670 533-541 UMLS/C0728853 denotes exposure
T17669 83-92 UMLS/C1524094 denotes cytokines
T17668 27-36 UMLS/C1524094 denotes cytokines
T17667 254-261 UMLS/C2349977 denotes studies

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T18788 1603-1608 NN denotes serum
T18787 1600-1602 NN denotes RA
T18786 1597-1599 IN denotes in
T18785 1589-1596 JJ denotes present
T18784 1586-1588 VB denotes be
T18783 1582-1585 MD denotes may
T18782 1572-1581 NN denotes signaling
T18781 1566-1571 NN denotes STAT1
T18780 1563-1565 IN denotes of
T18779 1552-1562 NN denotes inhibitors
T18778 1547-1551 IN denotes that
T18777 1544-1546 CC denotes or
T18776 1542-1543 -COMMA- denotes ,
T18775 1532-1542 NN denotes activation
T18774 1526-1531 NN denotes STAT3
T18773 1521-1525 IN denotes with
T18772 1512-1520 VB denotes compared
T18771 1509-1511 IN denotes as
T18770 1498-1508 NN denotes activation
T18769 1492-1497 NN denotes STAT1
T18768 1488-1491 IN denotes for
T18767 1479-1487 VB denotes required
T18766 1476-1478 VB denotes be
T18765 1472-1475 MD denotes may
T18764 1467-1471 NN denotes IL-6
T18763 1464-1466 IN denotes of
T18762 1449-1463 NN denotes concentrations
T18761 1442-1448 JJ denotes higher
T18760 1437-1441 RB denotes much
T18759 1432-1436 IN denotes that
T18758 1423-1431 VB denotes suggests
T18757 1417-1422 NN denotes serum
T18756 1414-1416 NN denotes RA
T18755 1411-1413 IN denotes by
T18754 1400-1410 NN denotes activation
T18753 1394-1399 NN denotes STAT1
T18752 1391-1393 IN denotes of
T18751 1386-1390 NN denotes lack
T18750 1382-1385 DT denotes The
T18749 1372-1380 NN denotes patients
T18748 1369-1371 NN denotes RA
T18747 1362-1368 JJ denotes active
T18746 1359-1361 IN denotes of
T18745 1354-1358 NN denotes sera
T18744 1351-1353 IN denotes in
T18743 1341-1350 VB denotes contained
T18742 1334-1340 NN denotes factor
T18741 1317-1333 JJ denotes STAT3-activating
T18740 1308-1316 JJ denotes dominant
T18739 1304-1307 DT denotes the
T18738 1301-1303 VB denotes is
T18737 1296-1300 NN denotes IL-6
T18736 1291-1295 IN denotes that
T18735 1282-1290 VB denotes indicate
T18734 1274-1281 NN denotes results
T18733 1268-1273 DT denotes These
T18732 1265-1266 -RRB- denotes )
T18731 1263-1265 NN denotes 5a
T18730 1258-1262 NN denotes Fig.
T18729 1257-1258 -LRB- denotes (
T18728 1248-1256 NN denotes activity
T18727 1243-1247 NN denotes IL-6
T18726 1240-1242 IN denotes of
T18725 1225-1239 NN denotes neutralization
T18724 1222-1224 IN denotes by
T18723 1212-1221 VB denotes abolished
T18722 1205-1211 RB denotes mostly
T18721 1201-1204 VB denotes was
T18720 1190-1200 NN denotes activation
T18719 1184-1189 NN denotes STAT3
T18718 1179-1183 DT denotes this
T18717 1175-1178 CC denotes and
T18716 1173-1174 -COMMA- denotes ,
T18715 1168-1173 NN denotes STAT1
T18714 1164-1167 RB denotes not
T18713 1160-1163 CC denotes but
T18712 1154-1159 NN denotes STAT3
T18711 1151-1153 IN denotes of
T18710 1135-1150 NN denotes phosphorylation
T18709 1126-1134 NN denotes tyrosine
T18708 1119-1125 VB denotes induce
T18707 1116-1118 TO denotes to
T18706 1111-1115 JJ denotes able
T18705 1107-1110 VB denotes was
T18704 1101-1106 NN denotes serum
T18703 1098-1100 NN denotes RA
T18702 1088-1096 NN denotes analysis
T18701 1083-1087 NN denotes blot
T18700 1075-1082 JJ denotes western
T18699 1072-1074 IN denotes by
T18698 1063-1071 VB denotes examined
T18697 1059-1062 VB denotes was
T18696 1043-1058 NN denotes phosphorylation
T18695 1038-1042 NN denotes STAT
T18694 1034-1037 CC denotes and
T18693 1032-1033 -COMMA- denotes ,
T18692 1024-1032 NN denotes antibody
T18691 1016-1023 NN denotes control
T18690 1013-1015 CC denotes or
T18689 1004-1012 NN denotes antibody
T18688 994-1003 JJ denotes anti-IL-6
T18687 981-993 VB denotes neutralizing
T18686 977-980 CC denotes and
T18685 968-976 NN denotes patients
T18684 965-967 NN denotes RA
T18683 958-964 JJ denotes active
T18682 953-957 IN denotes from
T18681 947-952 NN denotes serum
T18680 945-946 NN denotes %
T18679 943-945 CD denotes 30
T18678 932-942 VB denotes containing
T18677 925-931 NN denotes medium
T18676 917-924 NN denotes culture
T18675 912-916 IN denotes with
T18674 908-911 NN denotes min
T18673 905-907 CD denotes 20
T18672 901-904 IN denotes for
T18671 891-900 VB denotes incubated
T18670 886-890 RB denotes thus
T18669 881-885 VB denotes were
T18668 875-880 NN denotes cells
T18667 873-874 NN denotes T
T18666 868-872 JJ denotes CD4+
T18665 861-867 JJ denotes Normal
T18664 858-859 -RRB- denotes ]
T18663 857-858 CD denotes 4
T18662 856-857 -LRB- denotes [
T18661 843-855 NN denotes observations
T18660 834-842 JJ denotes previous
T18659 829-833 IN denotes with
T18658 819-828 NN denotes agreement
T18657 816-818 IN denotes in
T18656 814-815 -COMMA- denotes ,
T18655 813-814 -RRB- denotes )
T18654 808-813 VB denotes shown
T18653 804-807 RB denotes not
T18652 799-803 NN denotes data
T18651 798-799 -LRB- denotes (
T18650 792-797 NN denotes cells
T18649 790-791 NN denotes T
T18648 785-789 JJ denotes CD4+
T18647 778-784 JJ denotes normal
T18646 775-777 IN denotes in
T18645 770-774 NN denotes IL-6
T18644 767-769 IN denotes by
T18643 757-766 VB denotes activated
T18642 753-756 VB denotes was
T18641 737-752 NN denotes phosphorylation
T18640 731-736 NN denotes STAT3
T18639 727-730 CC denotes and
T18638 721-726 NN denotes STAT1
T18637 716-720 CC denotes Both
T18636 712-714 NN denotes RA
T18635 705-711 JJ denotes active
T18634 702-704 IN denotes in
T18633 691-701 NN denotes inhibition
T18632 685-690 NN denotes IL-10
T18631 682-684 TO denotes to
T18630 671-681 NN denotes resistance
T18629 667-670 CC denotes and
T18628 656-666 NN denotes activation
T18627 650-655 NN denotes STAT3
T18626 640-649 JJ denotes sustained
T18625 634-639 PRP-DOLLAR- denotes their
T18624 630-633 IN denotes for
T18623 618-629 JJ denotes responsible
T18622 614-617 VB denotes was
T18621 602-613 NN denotes circulation
T18620 596-601 NN denotes blood
T18619 592-595 DT denotes the
T18595 474-482 VB denotes detected
T18594 463-473 RB denotes frequently
T18593 461-462 -COMMA- denotes ,
T18592 453-461 NN denotes patients
T18591 450-452 NN denotes RA
T18590 443-449 JJ denotes active
T18589 440-442 IN denotes of
T18588 435-439 NN denotes sera
T18587 432-434 IN denotes in
T18586 423-431 JJ denotes abundant
T18585 418-422 RB denotes also
T18584 415-417 VB denotes is
T18583 410-414 NN denotes IL-6
T18582 404-409 IN denotes Since
T18581 401-402 -RRB- denotes ]
T18580 399-401 CD denotes 31
T18579 398-399 -LRB- denotes [
T18578 392-397 NN denotes cells
T18577 380-391 JJ denotes mononuclear
T18576 377-379 IN denotes in
T18575 371-376 NN denotes STAT3
T18574 368-370 IN denotes of
T18573 357-367 NN denotes activation
T18572 344-356 JJ denotes constitutive
T18571 336-343 VB denotes induces
T18570 331-335 WDT denotes that
T18569 325-330 NN denotes fluid
T18568 316-324 JJ denotes synovial
T18567 313-315 NN denotes RA
T18566 310-312 IN denotes in
T18565 303-309 NN denotes factor
T18564 297-302 JJ denotes major
T18563 293-296 DT denotes the
T18562 290-292 VB denotes is
T18561 285-289 NN denotes IL-6
T18560 280-284 IN denotes that
T18559 267-279 VB denotes demonstrated
T18558 262-266 VB denotes have
T18557 254-261 NN denotes studies
T18556 245-253 JJ denotes previous
T18555 241-244 CC denotes but
T18554 239-240 -COMMA- denotes ,
T18553 238-239 -RRB- denotes ]
T18552 237-238 CD denotes 4
T18551 236-237 -LRB- denotes [
T18550 230-235 NN denotes IL-10
T18549 227-229 TO denotes to
T18548 218-226 NN denotes addition
T18547 215-217 IN denotes in
T18546 213-214 -COMMA- denotes ,
T18545 207-213 NN denotes factor
T18544 200-206 NN denotes growth
T18543 190-199 JJ denotes epidermal
T18542 186-189 CC denotes and
T18541 184-185 -COMMA- denotes ,
T18540 178-184 NN denotes factor
T18539 171-177 NN denotes growth
T18538 154-170 JJ denotes platelet-derived
T18537 152-153 -COMMA- denotes ,
T18536 151-152 -RRB- denotes )
T18535 150-151 NN denotes M
T18534 139-149 NN denotes oncostatin
T18533 135-138 CC denotes and
T18532 133-134 -COMMA- denotes ,
T18531 127-133 NN denotes factor
T18530 116-126 JJ denotes inhibitory
T18529 107-115 NN denotes leukemia
T18528 105-106 -COMMA- denotes ,
T18527 100-105 NN denotes IL-11
T18526 98-99 -COMMA- denotes ,
T18525 94-98 NN denotes IL-6
T18524 93-94 -LRB- denotes (
T18523 83-92 NN denotes cytokines
T18522 80-82 IN denotes of
T18521 73-79 NN denotes family
T18520 68-72 NN denotes IL-6
T18519 64-67 DT denotes the
T18518 61-63 IN denotes as
T18517 56-60 JJ denotes such
T18516 48-55 NN denotes factors
T18515 41-47 NN denotes growth
T18514 37-40 CC denotes and
T18513 27-36 NN denotes cytokines
T18512 22-26 JJ denotes many
T18511 19-21 IN denotes by
T18510 9-18 VB denotes activated
T18509 6-8 VB denotes is
T18508 0-5 NN denotes STAT3
T18618 589-591 IN denotes in
T18617 584-588 NN denotes IL-6
T18616 581-583 IN denotes of
T18615 566-580 NN denotes concentrations
T18614 561-565 JJ denotes high
T18613 558-560 TO denotes to
T18612 552-557 NN denotes cells
T18611 550-551 NN denotes T
T18610 545-549 JJ denotes CD4+
T18609 542-544 IN denotes of
T18608 533-541 NN denotes exposure
T18607 522-532 JJ denotes persistent
T18606 514-521 IN denotes whether
T18605 505-513 VB denotes examined
T18604 502-504 PRP denotes we
T18603 500-501 -COMMA- denotes ,
T18602 499-500 -RRB- denotes ]
T18601 497-499 CD denotes 27
T18600 496-497 -LRB- denotes [
T18599 490-495 NN denotes ng/ml
T18598 488-489 CD denotes 1
T18597 486-487 SYM denotes >
T18596 483-485 IN denotes at
R8976 T18508 T18509 arg1Of STAT3,is
R8977 T18508 T18510 arg2Of STAT3,activated
R8978 T18510 T18509 arg2Of activated,is
R8979 T18510 T18546 arg1Of activated,","
R8980 T18510 T18547 arg1Of activated,in
R8981 T18510 T18555 arg1Of activated,but
R8982 T18513 T18512 arg1Of cytokines,many
R8983 T18513 T18514 arg1Of cytokines,and
R8984 T18514 T18510 arg1Of and,activated
R8985 T18514 T18511 arg2Of and,by
R8986 T18514 T18518 arg1Of and,as
R8987 T18516 T18514 arg2Of factors,and
R8988 T18516 T18515 arg1Of factors,growth
R8989 T18518 T18517 arg1Of as,such
R8990 T18521 T18520 arg1Of family,IL-6
R8991 T18521 T18522 arg1Of family,of
R8992 T18521 T18542 arg1Of family,and
R8993 T18523 T18524 arg1Of cytokines,(
R8994 T18523 T18537 arg1Of cytokines,","
R8995 T18525 T18526 arg1Of IL-6,","
R8996 T18526 T18528 arg1Of ",",","
R8997 T18527 T18526 arg2Of IL-11,","
R8998 T18528 T18533 arg1Of ",",and
R8999 T18531 T18528 arg2Of factor,","
R9000 T18531 T18529 arg1Of factor,leukemia
R9001 T18531 T18530 arg1Of factor,inhibitory
R9002 T18533 T18524 arg2Of and,(
R9003 T18533 T18532 arg1Of and,","
R9004 T18535 T18533 arg2Of M,and
R9005 T18535 T18534 arg1Of M,oncostatin
R9006 T18536 T18524 arg3Of ),(
R9007 T18537 T18522 arg2Of ",",of
R9008 T18540 T18537 arg2Of factor,","
R9009 T18540 T18538 arg1Of factor,platelet-derived
R9010 T18540 T18539 arg1Of factor,growth
R9011 T18542 T18518 arg2Of and,as
R9012 T18542 T18519 arg1Of and,the
R9013 T18542 T18541 arg1Of and,","
R9014 T18545 T18542 arg2Of factor,and
R9015 T18545 T18543 arg1Of factor,epidermal
R9016 T18545 T18544 arg1Of factor,growth
R9017 T18548 T18547 arg2Of addition,in
R9018 T18548 T18549 arg1Of addition,to
R9019 T18550 T18549 arg2Of IL-10,to
R9020 T18550 T18551 arg1Of IL-10,[
R9021 T18552 T18551 arg2Of 4,[
R9022 T18553 T18551 arg3Of ],[
R9023 T18555 T18554 arg1Of but,","
R9024 T18557 T18556 arg1Of studies,previous
R9025 T18557 T18558 arg1Of studies,have
R9026 T18557 T18559 arg1Of studies,demonstrated
R9027 T18559 T18555 arg2Of demonstrated,but
R9028 T18559 T18558 arg2Of demonstrated,have
R9029 T18561 T18562 arg1Of IL-6,is
R9030 T18562 T18559 arg2Of is,demonstrated
R9031 T18562 T18560 arg1Of is,that
R9032 T18565 T18562 arg2Of factor,is
R9033 T18565 T18563 arg1Of factor,the
R9034 T18565 T18564 arg1Of factor,major
R9035 T18565 T18566 arg1Of factor,in
R9036 T18565 T18570 arg1Of factor,that
R9037 T18565 T18571 arg1Of factor,induces
R9038 T18569 T18566 arg2Of fluid,in
R9039 T18569 T18567 arg1Of fluid,RA
R9040 T18569 T18568 arg1Of fluid,synovial
R9041 T18571 T18579 arg1Of induces,[
R9042 T18573 T18571 arg2Of activation,induces
R9043 T18573 T18572 arg1Of activation,constitutive
R9044 T18573 T18574 arg1Of activation,of
R9045 T18573 T18576 arg1Of activation,in
R9046 T18575 T18574 arg2Of STAT3,of
R9047 T18578 T18576 arg2Of cells,in
R9048 T18578 T18577 arg1Of cells,mononuclear
R9049 T18580 T18579 arg2Of 31,[
R9050 T18581 T18579 arg3Of ],[
R9051 T18583 T18584 arg1Of IL-6,is
R9052 T18583 T18586 arg1Of IL-6,abundant
R9053 T18584 T18582 arg2Of is,Since
R9054 T18584 T18585 arg1Of is,also
R9055 T18584 T18587 arg1Of is,in
R9056 T18586 T18584 arg2Of abundant,is
R9057 T18588 T18587 arg2Of sera,in
R9058 T18588 T18589 arg1Of sera,of
R9059 T18592 T18589 arg2Of patients,of
R9060 T18592 T18590 arg1Of patients,active
R9061 T18592 T18591 arg1Of patients,RA
R9062 T18592 T18593 arg1Of patients,","
R9063 T18592 T18595 arg2Of patients,detected
R9064 T18595 T18594 arg1Of detected,frequently
R9065 T18595 T18596 arg1Of detected,at
R9066 T18598 T18597 arg1Of 1,>
R9067 T18599 T18596 arg2Of ng/ml,at
R9068 T18599 T18598 arg1Of ng/ml,1
R9069 T18599 T18600 arg1Of ng/ml,[
R9070 T18601 T18600 arg2Of 27,[
R9071 T18602 T18600 arg3Of ],[
R9072 T18604 T18605 arg1Of we,examined
R9073 T18605 T18582 arg1Of examined,Since
R9074 T18605 T18603 arg1Of examined,","
R9075 T18608 T18607 arg1Of exposure,persistent
R9076 T18608 T18609 arg1Of exposure,of
R9077 T18608 T18613 arg1Of exposure,to
R9078 T18608 T18618 arg1Of exposure,in
R9079 T18608 T18622 arg1Of exposure,was
R9080 T18608 T18623 arg1Of exposure,responsible
R9081 T18612 T18609 arg2Of cells,of
R9082 T18612 T18610 arg1Of cells,CD4+
R9083 T18612 T18611 arg1Of cells,T
R9084 T18615 T18613 arg2Of concentrations,to
R9085 T18615 T18614 arg1Of concentrations,high
R9086 T18615 T18616 arg1Of concentrations,of
R9087 T18617 T18616 arg2Of IL-6,of
R9088 T18621 T18618 arg2Of circulation,in
R9089 T18621 T18619 arg1Of circulation,the
R9090 T18621 T18620 arg1Of circulation,blood
R9091 T18622 T18605 arg2Of was,examined
R9092 T18622 T18606 arg1Of was,whether
R9093 T18623 T18622 arg2Of responsible,was
R9094 T18623 T18624 arg1Of responsible,for
R9095 T18628 T18626 arg1Of activation,sustained
R9096 T18628 T18627 arg1Of activation,STAT3
R9097 T18628 T18629 arg1Of activation,and
R9098 T18629 T18624 arg2Of and,for
R9099 T18629 T18625 arg1Of and,their
R9100 T18629 T18634 arg1Of and,in
R9101 T18630 T18629 arg2Of resistance,and
R9102 T18630 T18631 arg1Of resistance,to
R9103 T18633 T18631 arg2Of inhibition,to
R9104 T18633 T18632 arg1Of inhibition,IL-10
R9105 T18636 T18634 arg2Of RA,in
R9106 T18636 T18635 arg1Of RA,active
R9107 T18638 T18639 arg1Of STAT1,and
R9108 T18640 T18639 arg2Of STAT3,and
R9109 T18641 T18637 arg1Of phosphorylation,Both
R9110 T18641 T18638 arg1Of phosphorylation,STAT1
R9111 T18641 T18640 arg1Of phosphorylation,STAT3
R9112 T18641 T18642 arg1Of phosphorylation,was
R9113 T18641 T18643 arg2Of phosphorylation,activated
R9114 T18643 T18642 arg2Of activated,was
R9115 T18643 T18646 arg1Of activated,in
R9116 T18643 T18656 arg1Of activated,","
R9117 T18643 T18657 arg1Of activated,in
R9118 T18645 T18643 arg1Of IL-6,activated
R9119 T18645 T18644 arg2Of IL-6,by
R9120 T18650 T18646 arg2Of cells,in
R9121 T18650 T18647 arg1Of cells,normal
R9122 T18650 T18648 arg1Of cells,CD4+
R9123 T18650 T18649 arg1Of cells,T
R9124 T18650 T18651 arg1Of cells,(
R9125 T18652 T18651 arg2Of data,(
R9126 T18652 T18654 arg2Of data,shown
R9127 T18654 T18653 arg1Of shown,not
R9128 T18655 T18651 arg3Of ),(
R9129 T18658 T18657 arg2Of agreement,in
R9130 T18658 T18659 arg1Of agreement,with
R9131 T18661 T18659 arg2Of observations,with
R9132 T18661 T18660 arg1Of observations,previous
R9133 T18661 T18662 arg1Of observations,[
R9134 T18663 T18662 arg2Of 4,[
R9135 T18664 T18662 arg3Of ],[
R9136 T18668 T18665 arg1Of cells,Normal
R9137 T18668 T18666 arg1Of cells,CD4+
R9138 T18668 T18667 arg1Of cells,T
R9139 T18668 T18669 arg1Of cells,were
R9140 T18668 T18671 arg2Of cells,incubated
R9141 T18668 T18687 arg1Of cells,neutralizing
R9142 T18671 T18670 arg1Of incubated,thus
R9143 T18671 T18672 arg1Of incubated,for
R9144 T18671 T18675 arg1Of incubated,with
R9145 T18671 T18686 arg1Of incubated,and
R9146 T18674 T18672 arg2Of min,for
R9147 T18674 T18673 arg1Of min,20
R9148 T18677 T18675 arg2Of medium,with
R9149 T18677 T18676 arg1Of medium,culture
R9150 T18677 T18678 arg1Of medium,containing
R9151 T18679 T18680 arg1Of 30,%
R9152 T18681 T18678 arg2Of serum,containing
R9153 T18681 T18679 arg1Of serum,30
R9154 T18681 T18682 arg1Of serum,from
R9155 T18685 T18682 arg2Of patients,from
R9156 T18685 T18683 arg1Of patients,active
R9157 T18685 T18684 arg1Of patients,RA
R9158 T18686 T18669 arg2Of and,were
R9159 T18686 T18694 arg1Of and,and
R9160 T18687 T18686 arg2Of neutralizing,and
R9161 T18689 T18690 arg1Of antibody,or
R9162 T18691 T18690 arg2Of control,or
R9163 T18692 T18687 arg2Of antibody,neutralizing
R9164 T18692 T18688 arg1Of antibody,anti-IL-6
R9165 T18692 T18689 arg1Of antibody,antibody
R9166 T18692 T18691 arg1Of antibody,control
R9167 T18694 T18693 arg1Of and,","
R9168 T18696 T18695 arg1Of phosphorylation,STAT
R9169 T18696 T18697 arg1Of phosphorylation,was
R9170 T18696 T18698 arg2Of phosphorylation,examined
R9171 T18698 T18694 arg2Of examined,and
R9172 T18698 T18697 arg2Of examined,was
R9173 T18702 T18698 arg1Of analysis,examined
R9174 T18702 T18699 arg2Of analysis,by
R9175 T18702 T18700 arg1Of analysis,western
R9176 T18702 T18701 arg1Of analysis,blot
R9177 T18704 T18703 arg1Of serum,RA
R9178 T18704 T18705 arg1Of serum,was
R9179 T18704 T18706 arg1Of serum,able
R9180 T18704 T18708 arg1Of serum,induce
R9181 T18705 T18717 arg1Of was,and
R9182 T18706 T18705 arg2Of able,was
R9183 T18708 T18706 arg2Of induce,able
R9184 T18708 T18707 arg1Of induce,to
R9185 T18710 T18708 arg2Of phosphorylation,induce
R9186 T18710 T18709 arg1Of phosphorylation,tyrosine
R9187 T18710 T18711 arg1Of phosphorylation,of
R9188 T18712 T18713 arg1Of STAT3,but
R9189 T18713 T18711 arg2Of but,of
R9190 T18713 T18714 arg1Of but,not
R9191 T18715 T18713 arg2Of STAT1,but
R9192 T18717 T18716 arg1Of and,","
R9193 T18720 T18718 arg1Of activation,this
R9194 T18720 T18719 arg1Of activation,STAT3
R9195 T18720 T18721 arg1Of activation,was
R9196 T18720 T18723 arg2Of activation,abolished
R9197 T18723 T18717 arg2Of abolished,and
R9198 T18723 T18721 arg2Of abolished,was
R9199 T18723 T18722 arg1Of abolished,mostly
R9200 T18725 T18723 arg1Of neutralization,abolished
R9201 T18725 T18724 arg2Of neutralization,by
R9202 T18725 T18726 arg1Of neutralization,of
R9203 T18728 T18726 arg2Of activity,of
R9204 T18728 T18727 arg1Of activity,IL-6
R9205 T18728 T18729 arg1Of activity,(
R9206 T18731 T18729 arg2Of 5a,(
R9207 T18731 T18730 arg1Of 5a,Fig.
R9208 T18732 T18729 arg3Of ),(
R9209 T18734 T18733 arg1Of results,These
R9210 T18734 T18735 arg1Of results,indicate
R9211 T18737 T18738 arg1Of IL-6,is
R9212 T18738 T18735 arg2Of is,indicate
R9213 T18738 T18736 arg1Of is,that
R9214 T18742 T18738 arg2Of factor,is
R9215 T18742 T18739 arg1Of factor,the
R9216 T18742 T18740 arg1Of factor,dominant
R9217 T18742 T18741 arg1Of factor,STAT3-activating
R9218 T18742 T18743 arg2Of factor,contained
R9219 T18743 T18744 arg1Of contained,in
R9220 T18745 T18744 arg2Of sera,in
R9221 T18745 T18746 arg1Of sera,of
R9222 T18749 T18746 arg2Of patients,of
R9223 T18749 T18747 arg1Of patients,active
R9224 T18749 T18748 arg1Of patients,RA
R9225 T18751 T18750 arg1Of lack,The
R9226 T18751 T18752 arg1Of lack,of
R9227 T18751 T18755 arg1Of lack,by
R9228 T18751 T18758 arg1Of lack,suggests
R9229 T18754 T18752 arg2Of activation,of
R9230 T18754 T18753 arg1Of activation,STAT1
R9231 T18757 T18755 arg2Of serum,by
R9232 T18757 T18756 arg1Of serum,RA
R9233 T18761 T18760 arg1Of higher,much
R9234 T18762 T18761 arg1Of concentrations,higher
R9235 T18762 T18763 arg1Of concentrations,of
R9236 T18762 T18765 arg1Of concentrations,may
R9237 T18762 T18766 arg1Of concentrations,be
R9238 T18762 T18767 arg2Of concentrations,required
R9239 T18764 T18763 arg2Of IL-6,of
R9240 T18767 T18759 arg1Of required,that
R9241 T18767 T18765 arg2Of required,may
R9242 T18767 T18766 arg2Of required,be
R9243 T18767 T18768 arg1Of required,for
R9244 T18767 T18771 arg1Of required,as
R9245 T18767 T18777 arg1Of required,or
R9246 T18770 T18768 arg2Of activation,for
R9247 T18770 T18769 arg1Of activation,STAT1
R9248 T18772 T18771 arg2Of compared,as
R9249 T18772 T18773 arg1Of compared,with
R9250 T18775 T18773 arg2Of activation,with
R9251 T18775 T18774 arg1Of activation,STAT3
R9252 T18777 T18758 arg2Of or,suggests
R9253 T18777 T18776 arg1Of or,","
R9254 T18778 T18777 arg2Of that,or
R9255 T18779 T18780 arg1Of inhibitors,of
R9256 T18779 T18783 arg1Of inhibitors,may
R9257 T18779 T18784 arg1Of inhibitors,be
R9258 T18779 T18785 arg1Of inhibitors,present
R9259 T18782 T18780 arg2Of signaling,of
R9260 T18782 T18781 arg1Of signaling,STAT1
R9261 T18784 T18778 arg2Of be,that
R9262 T18784 T18783 arg2Of be,may
R9263 T18785 T18784 arg2Of present,be
R9264 T18785 T18786 arg1Of present,in
R9265 T18788 T18786 arg2Of serum,in
R9266 T18788 T18787 arg1Of serum,RA

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T18143 285-289 Antecedent denotes IL-6
T18142 293-309 Anaphor denotes the major factor
T18141 139-151 Antecedent denotes oncostatin M
T18140 107-133 Antecedent denotes leukemia inhibitory factor
T18139 100-105 Antecedent denotes IL-11
T18138 94-98 Antecedent denotes IL-6
T18137 68-92 Anaphor denotes IL-6 family of cytokines
T18136 190-213 Antecedent denotes epidermal growth factor
T18135 154-184 Antecedent denotes platelet-derived growth factor
T18134 22-55 Anaphor denotes many cytokines and growth factors
T18147 1296-1300 Antecedent denotes IL-6
T18146 1334-1340 Anaphor denotes factor
T18145 293-309 Antecedent denotes the major factor
T18144 331-335 Anaphor denotes that
R8893 T18134 T18135 boundBy many cytokines and growth factors,platelet-derived growth factor
R8894 T18134 T18136 boundBy many cytokines and growth factors,epidermal growth factor
R8895 T18137 T18138 boundBy IL-6 family of cytokines,IL-6
R8896 T18137 T18139 boundBy IL-6 family of cytokines,IL-11
R8897 T18137 T18140 boundBy IL-6 family of cytokines,leukemia inhibitory factor
R8898 T18137 T18141 boundBy IL-6 family of cytokines,oncostatin M
R8899 T18142 T18143 boundBy the major factor,IL-6
R8900 T18144 T18142 boundBy that,the major factor
R8901 T18146 T18147 boundBy factor,IL-6

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T18162 410-414 Protein denotes IL-6
T18161 371-376 Protein denotes STAT3
T18160 285-289 Protein denotes IL-6
T18159 230-235 Protein denotes IL-10
T18158 190-213 Protein denotes epidermal growth factor
T18157 154-184 Protein denotes platelet-derived growth factor
T18156 139-151 Protein denotes oncostatin M
T18155 107-133 Protein denotes leukemia inhibitory factor
T18154 100-105 Protein denotes IL-11
T18153 94-98 Protein denotes IL-6
T18152 0-5 Protein denotes STAT3
T18183 1566-1571 Protein denotes STAT1
T18182 1526-1531 Protein denotes STAT3
T18181 1492-1497 Protein denotes STAT1
T18180 1467-1471 Protein denotes IL-6
T18179 1394-1399 Protein denotes STAT1
T18178 1317-1322 Protein denotes STAT3
T18177 1296-1300 Protein denotes IL-6
T18176 1243-1247 Protein denotes IL-6
T18175 1184-1189 Protein denotes STAT3
T18174 1168-1173 Protein denotes STAT1
T18173 1154-1159 Protein denotes STAT3
T18172 999-1003 Protein denotes IL-6
T18171 868-871 Protein denotes CD4
T18170 785-788 Protein denotes CD4
T18169 770-774 Protein denotes IL-6
T18168 731-736 Protein denotes STAT3
T18167 721-726 Protein denotes STAT1
T18166 685-690 Protein denotes IL-10
T18165 650-655 Protein denotes STAT3
T18164 584-588 Protein denotes IL-6
T18163 545-548 Protein denotes CD4

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T18429 868-871 http://www.uniprot.org/uniprot/P01730 denotes CD4
T18428 785-788 http://www.uniprot.org/uniprot/P01730 denotes CD4
T18427 545-548 http://www.uniprot.org/uniprot/P01730 denotes CD4
T18420 685-690 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T18419 230-235 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T18416 1526-1531 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18415 1317-1322 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18414 1184-1189 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18413 1154-1159 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18412 731-736 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18411 650-655 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18410 371-376 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18409 0-5 http://www.uniprot.org/uniprot/P40763 denotes STAT3
T18402 1467-1471 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18401 1296-1300 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18400 1243-1247 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18399 999-1003 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18398 770-774 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18397 584-588 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18396 410-414 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18395 285-289 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18394 94-98 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T18393 68-72 http://www.uniprot.org/uniprot/P05231 denotes IL-6

UBERON-AE

Id Subject Object Predicate Lexical cue
T17462 1603-1608 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T17461 1417-1422 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T17460 1101-1106 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T17459 947-952 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T17458 596-601 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T17457 316-330 http://purl.obolibrary.org/obo/UBERON_0001090 denotes synovial fluid

GO-BP

Id Subject Object Predicate Lexical cue
T18033 1572-1581 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T18032 1243-1256 http://purl.obolibrary.org/obo/GO_0004915 denotes IL-6 activity
T18031 737-766 http://purl.obolibrary.org/obo/GO_0042327 denotes phosphorylation was activated
T18030 596-613 http://purl.obolibrary.org/obo/GO_0008015 denotes blood circulation
T18029 171-199 http://purl.obolibrary.org/obo/GO_0070849 denotes growth factor, and epidermal
T18028 171-199 http://purl.obolibrary.org/obo/GO_0007174 denotes growth factor, and epidermal
T18027 200-206 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T18026 171-177 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T18025 41-47 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T18023 1135-1150 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T18022 1043-1058 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T18021 737-752 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation

GO-CC

Id Subject Object Predicate Lexical cue
T18245 1024-1032 http://purl.obolibrary.org/obo/GO_0042571 denotes antibody
T18244 1004-1012 http://purl.obolibrary.org/obo/GO_0042571 denotes antibody
T18243 1024-1032 http://purl.obolibrary.org/obo/GO_0019815 denotes antibody
T18242 1004-1012 http://purl.obolibrary.org/obo/GO_0019815 denotes antibody
T18237 875-880 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T18236 792-797 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T18235 552-557 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T18234 392-397 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

GO-MF

Id Subject Object Predicate Lexical cue
T18232 1243-1256 http://purl.obolibrary.org/obo/GO_0004915 denotes IL-6 activity
T18231 1024-1032 http://purl.obolibrary.org/obo/GO_0003823 denotes antibody
T18230 1004-1012 http://purl.obolibrary.org/obo/GO_0003823 denotes antibody
T18229 171-199 http://purl.obolibrary.org/obo/GO_0048408 denotes growth factor, and epidermal
T18228 171-199 http://purl.obolibrary.org/obo/GO_0005154 denotes growth factor, and epidermal
T18227 139-151 http://purl.obolibrary.org/obo/GO_0005147 denotes oncostatin M
T18226 100-105 http://purl.obolibrary.org/obo/GO_0005142 denotes IL-11
T18220 685-690 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T18219 230-235 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T18212 1467-1471 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18211 1296-1300 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18210 1243-1247 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18209 999-1003 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18208 770-774 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18207 584-588 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18206 410-414 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18205 285-289 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18204 94-98 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18203 68-72 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6

sentences

Id Subject Object Predicate Lexical cue
T18015 1382-1609 Sentence denotes The lack of STAT1 activation by RA serum suggests that much higher concentrations of IL-6 may be required for STAT1 activation as compared with STAT3 activation, or that inhibitors of STAT1 signaling may be present in RA serum.
T18014 1268-1381 Sentence denotes These results indicate that IL-6 is the dominant STAT3-activating factor contained in sera of active RA patients.
T18013 1098-1267 Sentence denotes RA serum was able to induce tyrosine phosphorylation of STAT3 but not STAT1, and this STAT3 activation was mostly abolished by neutralization of IL-6 activity (Fig. 5a).
T18012 861-1097 Sentence denotes Normal CD4+ T cells were thus incubated for 20 min with culture medium containing 30% serum from active RA patients and neutralizing anti-IL-6 antibody or control antibody, and STAT phosphorylation was examined by western blot analysis.
T18011 716-860 Sentence denotes Both STAT1 and STAT3 phosphorylation was activated by IL-6 in normal CD4+ T cells (data not shown), in agreement with previous observations [4].
T18010 404-715 Sentence denotes Since IL-6 is also abundant in sera of active RA patients, frequently detected at > 1 ng/ml [27], we examined whether persistent exposure of CD4+ T cells to high concentrations of IL-6 in the blood circulation was responsible for their sustained STAT3 activation and resistance to IL-10 inhibition in active RA.
T18009 0-403 Sentence denotes STAT3 is activated by many cytokines and growth factors such as the IL-6 family of cytokines (IL-6, IL-11, leukemia inhibitory factor, and oncostatin M), platelet-derived growth factor, and epidermal growth factor, in addition to IL-10 [4], but previous studies have demonstrated that IL-6 is the major factor in RA synovial fluid that induces constitutive activation of STAT3 in mononuclear cells [31].
T120 0-403 Sentence denotes STAT3 is activated by many cytokines and growth factors such as the IL-6 family of cytokines (IL-6, IL-11, leukemia inhibitory factor, and oncostatin M), platelet-derived growth factor, and epidermal growth factor, in addition to IL-10 [4], but previous studies have demonstrated that IL-6 is the major factor in RA synovial fluid that induces constitutive activation of STAT3 in mononuclear cells [31].
T121 404-715 Sentence denotes Since IL-6 is also abundant in sera of active RA patients, frequently detected at > 1 ng/ml [27], we examined whether persistent exposure of CD4+ T cells to high concentrations of IL-6 in the blood circulation was responsible for their sustained STAT3 activation and resistance to IL-10 inhibition in active RA.
T122 716-860 Sentence denotes Both STAT1 and STAT3 phosphorylation was activated by IL-6 in normal CD4+ T cells (data not shown), in agreement with previous observations [4].
T123 861-1097 Sentence denotes Normal CD4+ T cells were thus incubated for 20 min with culture medium containing 30% serum from active RA patients and neutralizing anti-IL-6 antibody or control antibody, and STAT phosphorylation was examined by western blot analysis.
T124 1098-1267 Sentence denotes RA serum was able to induce tyrosine phosphorylation of STAT3 but not STAT1, and this STAT3 activation was mostly abolished by neutralization of IL-6 activity (Fig. 5a).
T125 1268-1381 Sentence denotes These results indicate that IL-6 is the dominant STAT3-activating factor contained in sera of active RA patients.
T126 1382-1609 Sentence denotes The lack of STAT1 activation by RA serum suggests that much higher concentrations of IL-6 may be required for STAT1 activation as compared with STAT3 activation, or that inhibitors of STAT1 signaling may be present in RA serum.

simple1

Id Subject Object Predicate Lexical cue
T18476 1566-1571 Protein denotes STAT1
T18475 1526-1531 Protein denotes STAT3
T18474 1492-1497 Protein denotes STAT1
T18473 1467-1471 Protein denotes IL-6
T18472 1394-1399 Protein denotes STAT1
T18471 1317-1322 Protein denotes STAT3
T18470 1296-1300 Protein denotes IL-6
T18469 1243-1247 Protein denotes IL-6
T18468 1184-1189 Protein denotes STAT3
T18467 1168-1173 Protein denotes STAT1
T18466 1154-1159 Protein denotes STAT3
T18465 999-1003 Protein denotes IL-6
T18464 868-871 Protein denotes CD4
T18463 785-788 Protein denotes CD4
T18462 770-774 Protein denotes IL-6
T18461 731-736 Protein denotes STAT3
T18460 721-726 Protein denotes STAT1
T18459 685-690 Protein denotes IL-10
T18458 650-655 Protein denotes STAT3
T18457 584-588 Protein denotes IL-6
T18456 545-548 Protein denotes CD4
T18455 410-414 Protein denotes IL-6
T18454 371-376 Protein denotes STAT3
T18453 285-289 Protein denotes IL-6
T18452 230-235 Protein denotes IL-10
T18451 190-213 Protein denotes epidermal growth factor
T18450 154-184 Protein denotes platelet-derived growth factor
T18449 139-151 Protein denotes oncostatin M
T18448 107-133 Protein denotes leukemia inhibitory factor
T18447 100-105 Protein denotes IL-11
T18446 94-98 Protein denotes IL-6
T18445 0-5 Protein denotes STAT3

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T19832 1317-1322 Protein denotes STAT3
T19831 1296-1300 Protein denotes IL-6
T19830 1243-1247 Protein denotes IL-6
T19829 1184-1189 Protein denotes STAT3
T19828 1168-1173 Protein denotes STAT1
T19827 1154-1159 Protein denotes STAT3
T19826 999-1003 Protein denotes IL-6
T19825 868-871 Protein denotes CD4
T19824 785-788 Protein denotes CD4
T19823 770-774 Protein denotes IL-6
T19822 731-736 Protein denotes STAT3
T19821 721-726 Protein denotes STAT1
T19820 685-690 Protein denotes IL-10
T19819 650-655 Protein denotes STAT3
T19818 584-588 Protein denotes IL-6
T19817 545-548 Protein denotes CD4
T19816 410-414 Protein denotes IL-6
T19815 139-151 Protein denotes oncostatin M
T19814 107-133 Protein denotes leukemia inhibitory factor
T19813 100-105 Protein denotes IL-11
T19812 94-98 Protein denotes IL-6
T19811 0-5 Protein denotes STAT3
T19810 371-376 Protein denotes STAT3
T19809 285-289 Protein denotes IL-6
T19808 230-235 Protein denotes IL-10
T19807 190-213 Protein denotes epidermal growth factor
T19806 154-184 Protein denotes platelet-derived growth factor
T19878 1498-1508 Positive_regulation denotes activation
T19877 1532-1542 Positive_regulation denotes activation
T19876 1386-1390 Negative_regulation denotes lack
T19875 1400-1410 Positive_regulation denotes activation
T19874 1479-1487 Positive_regulation denotes required
T19873 1190-1200 Positive_regulation denotes activation
T19872 1119-1125 Positive_regulation denotes induce
T19871 1225-1239 Negative_regulation denotes neutralization
T19870 1135-1150 Phosphorylation denotes phosphorylation
T19869 1212-1221 Negative_regulation denotes abolished
T19868 737-752 Phosphorylation denotes phosphorylation
T19867 757-766 Positive_regulation denotes activated
T19866 691-701 Negative_regulation denotes inhibition
T19865 618-629 Positive_regulation denotes responsible
T19864 656-666 Positive_regulation denotes activation
T19863 474-482 Gene_expression denotes detected
T19862 336-343 Positive_regulation denotes induces
T19861 357-367 Positive_regulation denotes activation
T19860 9-18 Positive_regulation denotes activated
T19837 1566-1571 Protein denotes STAT1
T19836 1526-1531 Protein denotes STAT3
T19835 1492-1497 Protein denotes STAT1
T19834 1467-1471 Protein denotes IL-6
T19833 1394-1399 Protein denotes STAT1
R10063 T19835 T19878 themeOf STAT1,activation
R10064 T19836 T19877 themeOf STAT3,activation
R10071 T19861 T19862 themeOf activation,induces
R10072 T19864 T19865 themeOf activation,responsible
R10073 T19868 T19867 themeOf phosphorylation,activated
R10074 T19868 T19867 themeOf phosphorylation,activated
R10075 T19870 T19872 themeOf phosphorylation,induce
R10076 T19870 T19872 themeOf phosphorylation,induce
R10077 T19873 T19869 themeOf activation,abolished
R10078 T19875 T19876 themeOf activation,lack
R10079 T19878 T19874 themeOf activation,required
R10042 T19808 T19860 themeOf IL-10,activated
R10043 T19810 T19861 themeOf STAT3,activation
R10044 T19811 T19860 themeOf STAT3,activated
R10045 T19814 T19860 causeOf leukemia inhibitory factor,activated
R10046 T19814 T19860 causeOf leukemia inhibitory factor,activated
R10047 T19816 T19863 themeOf IL-6,detected
R10048 T19819 T19864 themeOf STAT3,activation
R10049 T19820 T19866 themeOf IL-10,inhibition
R10050 T19821 T19868 themeOf STAT1,phosphorylation
R10051 T19821 T19867 themeOf STAT1,activated
R10052 T19822 T19868 themeOf STAT3,phosphorylation
R10053 T19822 T19867 themeOf STAT3,activated
R10054 T19823 T19867 causeOf IL-6,activated
R10055 T19823 T19867 causeOf IL-6,activated
R10056 T19823 T19867 causeOf IL-6,activated
R10057 T19823 T19867 causeOf IL-6,activated
R10058 T19827 T19870 themeOf STAT3,phosphorylation
R10059 T19828 T19870 themeOf STAT1,phosphorylation
R10060 T19829 T19873 themeOf STAT3,activation
R10061 T19830 T19871 themeOf IL-6,neutralization
R10062 T19833 T19875 themeOf STAT1,activation

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T18952 1566-1571 Protein denotes STAT1
T18951 1526-1531 Protein denotes STAT3
T18950 1492-1497 Protein denotes STAT1
T18949 1467-1471 Protein denotes IL-6
T18948 1394-1399 Protein denotes STAT1
T18947 1317-1322 Protein denotes STAT3
T18946 1296-1300 Protein denotes IL-6
T18945 1243-1247 Protein denotes IL-6
T18944 1184-1189 Protein denotes STAT3
T18943 1168-1173 Protein denotes STAT1
T18942 1154-1159 Protein denotes STAT3
T18941 999-1003 Protein denotes IL-6
T18940 868-871 Protein denotes CD4
T18939 785-788 Protein denotes CD4
T18938 770-774 Protein denotes IL-6
T18937 731-736 Protein denotes STAT3
T18936 721-726 Protein denotes STAT1
T18935 685-690 Protein denotes IL-10
T18934 650-655 Protein denotes STAT3
T18933 584-588 Protein denotes IL-6
T18932 545-548 Protein denotes CD4
T18931 410-414 Protein denotes IL-6
T18930 139-151 Protein denotes oncostatin M
T18929 107-133 Protein denotes leukemia inhibitory factor
T18928 100-105 Protein denotes IL-11
T18927 94-98 Protein denotes IL-6
T18926 0-5 Protein denotes STAT3
T18925 371-376 Protein denotes STAT3
T18924 285-289 Protein denotes IL-6
T18923 230-235 Protein denotes IL-10
T18922 190-213 Protein denotes epidermal growth factor
T18921 154-184 Protein denotes platelet-derived growth factor
T18991 1498-1508 Positive_regulation denotes activation
T18990 1532-1542 Positive_regulation denotes activation
T18989 1386-1390 Negative_regulation denotes lack
T18988 1119-1125 Positive_regulation denotes induce
T18987 1212-1221 Negative_regulation denotes abolished
T18986 1135-1150 Phosphorylation denotes phosphorylation
T18985 1190-1200 Positive_regulation denotes activation
T18984 1225-1239 Negative_regulation denotes neutralization
T18983 737-752 Phosphorylation denotes phosphorylation
T18982 757-766 Positive_regulation denotes activated
T18981 618-629 Positive_regulation denotes responsible
T18980 691-701 Negative_regulation denotes inhibition
T18979 640-649 Positive_regulation denotes sustained
T18978 656-666 Positive_regulation denotes activation
T18977 9-18 Positive_regulation denotes activated
T18976 336-343 Positive_regulation denotes induces
T18975 357-367 Positive_regulation denotes activation
T18993 1400-1410 Positive_regulation denotes activation
T18992 1479-1487 Positive_regulation denotes required
R9401 T18923 T18977 themeOf IL-10,activated
R9402 T18925 T18975 themeOf STAT3,activation
R9403 T18926 T18977 themeOf STAT3,activated
R9404 T18934 T18978 themeOf STAT3,activation
R9405 T18935 T18980 themeOf IL-10,inhibition
R9406 T18936 T18983 themeOf STAT1,phosphorylation
R9407 T18936 T18982 themeOf STAT1,activated
R9408 T18937 T18983 themeOf STAT3,phosphorylation
R9409 T18937 T18982 themeOf STAT3,activated
R9410 T18938 T18982 causeOf IL-6,activated
R9411 T18938 T18982 causeOf IL-6,activated
R9412 T18942 T18986 themeOf STAT3,phosphorylation
R9413 T18943 T18986 themeOf STAT1,phosphorylation
R9414 T18944 T18985 themeOf STAT3,activation
R9415 T18945 T18984 themeOf IL-6,neutralization
R9416 T18948 T18993 themeOf STAT1,activation
R9417 T18950 T18991 themeOf STAT1,activation
R9418 T18951 T18990 themeOf STAT3,activation
R9427 T18975 T18976 themeOf activation,induces
R9428 T18978 T18981 themeOf activation,responsible
R9429 T18978 T18979 themeOf activation,sustained
R9430 T18985 T18987 themeOf activation,abolished
R9431 T18986 T18988 themeOf phosphorylation,induce
R9432 T18986 T18988 themeOf phosphorylation,induce
R9433 T18991 T18992 themeOf activation,required
R9434 T18993 T18989 themeOf activation,lack

DLUT931

Id Subject Object Predicate Lexical cue
T19452 285-289 Protein denotes IL-6
T19451 230-235 Protein denotes IL-10
T19450 190-213 Protein denotes epidermal growth factor
T19449 154-184 Protein denotes platelet-derived growth factor
T19523 1479-1487 Positive_regulation denotes required
T19522 1386-1390 Negative_regulation denotes lack
T19521 1552-1562 Negative_regulation denotes inhibitors
T19520 1532-1542 Positive_regulation denotes activation
T19519 1498-1508 Positive_regulation denotes activation
T19518 1400-1410 Positive_regulation denotes activation
T19517 1323-1333 Positive_regulation denotes activating
T19516 1119-1125 Positive_regulation denotes induce
T19515 1212-1221 Negative_regulation denotes abolished
T19514 1190-1200 Positive_regulation denotes activation
T19513 1135-1150 Phosphorylation denotes phosphorylation
T19512 757-766 Positive_regulation denotes activated
T19511 737-752 Phosphorylation denotes phosphorylation
T19510 671-681 Positive_regulation denotes resistance
T19509 640-649 Positive_regulation denotes sustained
T19508 618-629 Positive_regulation denotes responsible
T19507 691-701 Negative_regulation denotes inhibition
T19506 656-666 Positive_regulation denotes activation
T19505 474-482 Gene_expression denotes detected
T19504 336-343 Positive_regulation denotes induces
T19503 357-367 Positive_regulation denotes activation
T19502 9-18 Positive_regulation denotes activated
T19480 1566-1571 Protein denotes STAT1
T19479 1526-1531 Protein denotes STAT3
T19478 1492-1497 Protein denotes STAT1
T19477 1467-1471 Protein denotes IL-6
T19476 1394-1399 Protein denotes STAT1
T19475 1317-1322 Protein denotes STAT3
T19474 1296-1300 Protein denotes IL-6
T19473 1243-1247 Protein denotes IL-6
T19472 1184-1189 Protein denotes STAT3
T19471 1168-1173 Protein denotes STAT1
T19470 1154-1159 Protein denotes STAT3
T19469 999-1003 Protein denotes IL-6
T19468 868-871 Protein denotes CD4
T19467 785-788 Protein denotes CD4
T19466 770-774 Protein denotes IL-6
T19465 731-736 Protein denotes STAT3
T19464 721-726 Protein denotes STAT1
T19463 685-690 Protein denotes IL-10
T19462 650-655 Protein denotes STAT3
T19461 584-588 Protein denotes IL-6
T19460 545-548 Protein denotes CD4
T19459 410-414 Protein denotes IL-6
T19458 139-151 Protein denotes oncostatin M
T19457 107-133 Protein denotes leukemia inhibitory factor
T19456 100-105 Protein denotes IL-11
T19455 94-98 Protein denotes IL-6
T19454 0-5 Protein denotes STAT3
T19453 371-376 Protein denotes STAT3
R9884 T19451 T19502 themeOf IL-10,activated
R9885 T19452 T19504 causeOf IL-6,induces
R9886 T19453 T19503 themeOf STAT3,activation
R9887 T19454 T19502 themeOf STAT3,activated
R9888 T19459 T19505 themeOf IL-6,detected
R9889 T19462 T19506 themeOf STAT3,activation
R9890 T19463 T19507 themeOf IL-10,inhibition
R9891 T19464 T19511 themeOf STAT1,phosphorylation
R9892 T19464 T19512 themeOf STAT1,activated
R9893 T19465 T19511 themeOf STAT3,phosphorylation
R9894 T19465 T19512 themeOf STAT3,activated
R9895 T19466 T19512 causeOf IL-6,activated
R9896 T19466 T19512 causeOf IL-6,activated
R9897 T19466 T19512 causeOf IL-6,activated
R9898 T19466 T19512 causeOf IL-6,activated
R9899 T19470 T19513 themeOf STAT3,phosphorylation
R9900 T19471 T19513 themeOf STAT1,phosphorylation
R9901 T19472 T19514 themeOf STAT3,activation
R9902 T19474 T19517 causeOf IL-6,activating
R9903 T19475 T19517 themeOf STAT3,activating
R9904 T19476 T19518 themeOf STAT1,activation
R9905 T19478 T19519 themeOf STAT1,activation
R9906 T19479 T19520 themeOf STAT3,activation
R9907 T19480 T19521 themeOf STAT1,inhibitors
R9916 T19503 T19504 themeOf activation,induces
R9917 T19506 T19508 themeOf activation,responsible
R9918 T19506 T19509 themeOf activation,sustained
R9919 T19507 T19510 themeOf inhibition,resistance
R9920 T19511 T19512 themeOf phosphorylation,activated
R9921 T19511 T19512 themeOf phosphorylation,activated
R9922 T19513 T19516 themeOf phosphorylation,induce
R9923 T19513 T19516 themeOf phosphorylation,induce
R9924 T19514 T19515 themeOf activation,abolished
R9925 T19518 T19522 themeOf activation,lack
R9926 T19519 T19523 themeOf activation,required

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T19801 685-714 Negative_regulation denotes IL-10 inhibition in active RA
T19798 1521-1542 Positive_regulation denotes with STAT3 activation
T19797 1038-1096 Phosphorylation denotes STAT phosphorylation was examined by western blot analysis
T19796 344-402 Positive_regulation denotes constitutive activation of STAT3 in mononuclear cells [31]
T19795 1126-1173 Phosphorylation denotes tyrosine phosphorylation of STAT3 but not STAT1
T19794 0-18 Positive_regulation denotes STAT3 is activated
T19793 1566-1581 Positive_regulation denotes STAT1 signaling
T19789 1179-1200 Positive_regulation denotes this STAT3 activation
T19787 1391-1410 Positive_regulation denotes of STAT1 activation
T19745 873-880 Entity denotes T cells
T19744 380-402 Entity denotes mononuclear cells [31]
T19742 1168-1173 Protein denotes STAT1
T19741 650-655 Protein denotes STAT3
T19740 1526-1531 Protein denotes STAT3
T19738 1243-1247 Protein denotes IL-6
T19737 1394-1399 Protein denotes STAT1
T19732 1258-1261 Protein denotes Fig
T19731 450-452 Protein denotes RA
T19730 731-736 Protein denotes STAT3
T19729 994-1032 Entity denotes anti-IL-6 antibody or control antibody
T19726 581-588 Protein denotes of IL-6
T19721 190-213 Protein denotes epidermal growth factor
T19720 1566-1571 Protein denotes STAT1
T19717 685-690 Protein denotes IL-10
T19716 94-98 Protein denotes IL-6
T19715 1492-1497 Protein denotes STAT1
T19713 1547-1581 Entity denotes that inhibitors of STAT1 signaling
T19712 1151-1159 Protein denotes of STAT3
T19711 778-814 Entity denotes normal CD4+ T cells (data not shown)
T19710 313-315 Protein denotes RA
T19709 410-414 Protein denotes IL-6
T19707 139-151 Protein denotes oncostatin M
T19706 0-5 Protein denotes STAT3
T19705 767-774 Protein denotes by IL-6
T19703 435-462 Protein denotes sera of active RA patients,
T19783 1492-1508 Positive_regulation denotes STAT1 activation
T19781 1354-1380 Protein denotes sera of active RA patients
T19780 230-240 Protein denotes IL-10 [4],
T19779 285-289 Protein denotes IL-6
T19778 861-871 Protein denotes Normal CD4
T19777 1004-1012 Entity denotes antibody
T19776 83-152 Protein denotes cytokines (IL-6, IL-11, leukemia inhibitory factor, and oncostatin M)
T19771 1038-1042 Protein denotes STAT
T19769 1464-1471 Protein denotes of IL-6
T19768 107-133 Protein denotes leukemia inhibitory factor
T19766 542-557 Entity denotes of CD4+ T cells
T19764 368-376 Protein denotes of STAT3
T19763 1296-1300 Protein denotes IL-6
T19762 154-184 Protein denotes platelet-derived growth factor
T19761 1600-1602 Entity denotes RA
T19760 100-105 Protein denotes IL-11
T19758 965-967 Protein denotes RA
T19756 1184-1189 Protein denotes STAT3
T19755 68-72 Protein denotes IL-6
T19754 1126-1134 Entity denotes tyrosine
T19753 1411-1416 Protein denotes by RA
T19752 705-714 Protein denotes active RA
T19751 1369-1371 Protein denotes RA
T19750 721-726 Protein denotes STAT1
T19747 1098-1100 Protein denotes RA
R10018 T19706 T19794 themeOf STAT3,STAT3 is activated
R10019 T19712 T19795 themeOf of STAT3,tyrosine phosphorylation of STAT3 but not STAT1
R10020 T19715 T19783 themeOf STAT1,STAT1 activation
R10021 T19717 T19801 themeOf IL-10,IL-10 inhibition in active RA
R10022 T19720 T19793 causeOf STAT1,STAT1 signaling
R10028 T19737 T19787 themeOf STAT1,of STAT1 activation
R10029 T19740 T19798 themeOf STAT3,with STAT3 activation
R10031 T19754 T19712 partOf tyrosine,of STAT3
R10032 T19754 T19795 siteOf tyrosine,tyrosine phosphorylation of STAT3 but not STAT1
R10033 T19756 T19789 themeOf STAT3,this STAT3 activation
R10034 T19764 T19796 themeOf of STAT3,constitutive activation of STAT3 in mononuclear cells [31]
R10036 T19771 T19797 themeOf STAT,STAT phosphorylation was examined by western blot analysis

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T19309 1608-1609 . denotes .
T19308 1603-1608 NN denotes serum
T19307 1600-1602 NNP denotes RA
T19306 1597-1599 IN denotes in
T19305 1589-1596 JJ denotes present
T19304 1586-1588 VB denotes be
T19303 1582-1585 MD denotes may
T19302 1572-1581 VBG denotes signaling
T19301 1566-1571 CD denotes STAT1
T19300 1563-1565 IN denotes of
T19299 1552-1562 NNS denotes inhibitors
T19298 1547-1551 DT denotes that
T19297 1544-1546 CC denotes or
T19296 1542-1543 , denotes ,
T19295 1532-1542 NN denotes activation
T19294 1526-1531 CD denotes STAT3
T19293 1521-1525 IN denotes with
T19292 1512-1520 VBN denotes compared
T19291 1509-1511 IN denotes as
T19290 1498-1508 NN denotes activation
T19289 1492-1497 CD denotes STAT1
T19288 1488-1491 IN denotes for
T19287 1479-1487 VBN denotes required
T19286 1476-1478 VB denotes be
T19285 1472-1475 MD denotes may
T19284 1467-1471 NN denotes IL-6
T19283 1464-1466 IN denotes of
T19282 1449-1463 NNS denotes concentrations
T19281 1442-1448 JJR denotes higher
T19280 1437-1441 RB denotes much
T19279 1432-1436 IN denotes that
T19278 1423-1431 VBZ denotes suggests
T19277 1417-1422 NN denotes serum
T19276 1414-1416 NNP denotes RA
T19275 1411-1413 IN denotes by
T19274 1400-1410 NN denotes activation
T19273 1394-1399 CD denotes STAT1
T19272 1391-1393 IN denotes of
T19271 1386-1390 NN denotes lack
T19270 1382-1385 DT denotes The
T19269 1380-1381 . denotes .
T19268 1372-1380 NNS denotes patients
T19267 1369-1371 NNP denotes RA
T19266 1362-1368 JJ denotes active
T19265 1359-1361 IN denotes of
T19264 1354-1358 NN denotes sera
T19263 1351-1353 IN denotes in
T19262 1341-1350 VBN denotes contained
T19261 1334-1340 NN denotes factor
T19260 1317-1333 JJ denotes STAT3-activating
T19259 1308-1316 JJ denotes dominant
T19258 1304-1307 DT denotes the
T19257 1301-1303 VBZ denotes is
T19256 1296-1300 NNP denotes IL-6
T19255 1291-1295 IN denotes that
T19254 1282-1290 VBP denotes indicate
T19253 1274-1281 NNS denotes results
T19252 1268-1273 DT denotes These
T19251 1266-1267 . denotes .
T19250 1265-1266 -RRB- denotes )
T19249 1263-1265 CD denotes 5a
T19248 1258-1262 NNP denotes Fig.
T19247 1257-1258 -LRB- denotes (
T19246 1248-1256 NN denotes activity
T19245 1243-1247 NN denotes IL-6
T19244 1240-1242 IN denotes of
T19243 1225-1239 NN denotes neutralization
T19242 1222-1224 IN denotes by
T19241 1212-1221 VBN denotes abolished
T19240 1205-1211 RB denotes mostly
T19239 1201-1204 VBD denotes was
T19238 1190-1200 NN denotes activation
T19237 1184-1189 CD denotes STAT3
T19178 857-858 CD denotes 4
T19236 1179-1183 DT denotes this
T19235 1175-1178 CC denotes and
T19234 1173-1174 , denotes ,
T19233 1168-1173 NNP denotes STAT1
T19232 1164-1167 RB denotes not
T19231 1160-1163 CC denotes but
T19230 1154-1159 CD denotes STAT3
T19229 1151-1153 IN denotes of
T19228 1135-1150 NN denotes phosphorylation
T19227 1126-1134 JJ denotes tyrosine
T19226 1119-1125 VB denotes induce
T19225 1116-1118 TO denotes to
T19224 1111-1115 JJ denotes able
T19223 1107-1110 VBD denotes was
T19222 1101-1106 NN denotes serum
T19221 1098-1100 NNP denotes RA
T19220 1096-1097 . denotes .
T19219 1088-1096 NN denotes analysis
T19218 1083-1087 NN denotes blot
T19217 1075-1082 JJ denotes western
T19216 1072-1074 IN denotes by
T19215 1063-1071 VBN denotes examined
T19214 1059-1062 VBD denotes was
T19213 1043-1058 NN denotes phosphorylation
T19212 1038-1042 NNP denotes STAT
T19211 1034-1037 CC denotes and
T19210 1032-1033 , denotes ,
T19209 1024-1032 NN denotes antibody
T19208 1016-1023 NN denotes control
T19207 1013-1015 CC denotes or
T19206 1004-1012 NN denotes antibody
T19205 994-1003 JJ denotes anti-IL-6
T19204 981-993 VBG denotes neutralizing
T19203 977-980 CC denotes and
T19202 968-976 NNS denotes patients
T19201 965-967 NNP denotes RA
T19200 958-964 JJ denotes active
T19199 953-957 IN denotes from
T19198 947-952 NN denotes serum
T19197 945-946 NN denotes %
T19196 943-945 CD denotes 30
T19195 932-942 VBG denotes containing
T19194 925-931 NN denotes medium
T19193 917-924 NN denotes culture
T19192 912-916 IN denotes with
T19191 908-911 NN denotes min
T19190 905-907 CD denotes 20
T19189 901-904 IN denotes for
T19188 891-900 VBN denotes incubated
T19187 886-890 RB denotes thus
T19186 881-885 VBD denotes were
T19185 875-880 NNS denotes cells
T19184 873-874 NNP denotes T
T19183 871-872 CD denotes +
T19182 868-871 NNP denotes CD4
T19181 861-867 JJ denotes Normal
T19180 859-860 . denotes .
T19179 858-859 NNP denotes ]
T19177 856-857 VBP denotes [
T19176 843-855 NNS denotes observations
T19175 834-842 JJ denotes previous
T19174 829-833 IN denotes with
T19173 819-828 NN denotes agreement
T19172 816-818 IN denotes in
T19171 814-815 , denotes ,
T19170 813-814 -RRB- denotes )
T19169 808-813 VBN denotes shown
T19168 804-807 RB denotes not
T19167 799-803 NNS denotes data
T19166 798-799 -LRB- denotes (
T19165 792-797 NNS denotes cells
T19164 790-791 NNP denotes T
T19163 788-789 CD denotes +
T19162 785-788 NNP denotes CD4
T19161 778-784 JJ denotes normal
T19160 775-777 IN denotes in
T19159 770-774 NN denotes IL-6
T19158 767-769 IN denotes by
T19157 757-766 VBN denotes activated
T19156 753-756 VBD denotes was
T19155 737-752 NN denotes phosphorylation
T19154 731-736 CD denotes STAT3
T19153 727-730 CC denotes and
T19152 721-726 CD denotes STAT1
T19151 716-720 DT denotes Both
T19150 714-715 . denotes .
T19149 712-714 NNP denotes RA
T19148 705-711 JJ denotes active
T19147 702-704 IN denotes in
T19146 691-701 NN denotes inhibition
T19145 685-690 NNP denotes IL-10
T19144 682-684 TO denotes to
T19143 671-681 NN denotes resistance
T19142 667-670 CC denotes and
T19141 656-666 NN denotes activation
T19140 650-655 CD denotes STAT3
T19139 640-649 VBN denotes sustained
T19138 634-639 PRP$ denotes their
T19137 630-633 IN denotes for
T19136 618-629 JJ denotes responsible
T19135 614-617 VBD denotes was
T19134 602-613 NN denotes circulation
T19133 596-601 NN denotes blood
T19132 592-595 DT denotes the
T19131 589-591 IN denotes in
T19130 584-588 NN denotes IL-6
T19129 581-583 IN denotes of
T19128 566-580 NNS denotes concentrations
T19127 561-565 JJ denotes high
T19126 558-560 TO denotes to
T19125 552-557 NNS denotes cells
T19124 550-551 NNP denotes T
T19123 548-549 CD denotes +
T19122 545-548 CD denotes CD4
T19121 542-544 IN denotes of
T19120 533-541 NN denotes exposure
T19119 522-532 JJ denotes persistent
T19118 514-521 IN denotes whether
T19117 505-513 VBD denotes examined
T19116 502-504 PRP denotes we
T19115 500-501 , denotes ,
T19114 499-500 NNP denotes ]
T19113 497-499 CD denotes 27
T19112 496-497 NNP denotes [
T19111 490-495 VBN denotes ng/ml
T19110 488-489 CD denotes 1
T19109 486-487 CD denotes >
T19108 483-485 IN denotes at
T19107 474-482 VBN denotes detected
T19106 463-473 RB denotes frequently
T19105 461-462 , denotes ,
T19104 453-461 NNS denotes patients
T19103 450-452 NNP denotes RA
T19102 443-449 JJ denotes active
T19101 440-442 IN denotes of
T19100 435-439 NN denotes sera
T19099 432-434 IN denotes in
T19098 423-431 JJ denotes abundant
T19097 418-422 RB denotes also
T19096 415-417 VBZ denotes is
T19095 410-414 NNP denotes IL-6
T19094 404-409 IN denotes Since
T19093 402-403 . denotes .
T19092 401-402 NNP denotes ]
T19091 399-401 CD denotes 31
T19090 398-399 NNP denotes [
T19089 392-397 NNS denotes cells
T19088 380-391 NN denotes mononuclear
T19087 377-379 IN denotes in
T19086 371-376 CD denotes STAT3
T19085 368-370 IN denotes of
T19084 357-367 NN denotes activation
T19083 344-356 JJ denotes constitutive
T19082 336-343 VBZ denotes induces
T19081 331-335 WDT denotes that
T19080 325-330 NN denotes fluid
T19079 316-324 JJ denotes synovial
T19078 313-315 NNP denotes RA
T19077 310-312 IN denotes in
T19076 303-309 NN denotes factor
T19075 297-302 JJ denotes major
T19074 293-296 DT denotes the
T19073 290-292 VBZ denotes is
T19072 285-289 NNP denotes IL-6
T19071 280-284 IN denotes that
T19070 267-279 VBN denotes demonstrated
T19069 262-266 VBP denotes have
T19068 254-261 NNS denotes studies
T19067 245-253 JJ denotes previous
T19066 241-244 CC denotes but
T19065 239-240 , denotes ,
T19064 238-239 NNP denotes ]
T19063 237-238 CD denotes 4
T19062 236-237 NNP denotes [
T19061 230-235 NNP denotes IL-10
T19060 227-229 TO denotes to
T19059 218-226 NN denotes addition
T19058 215-217 IN denotes in
T19057 213-214 , denotes ,
T19056 207-213 NN denotes factor
T19055 200-206 NN denotes growth
T19054 190-199 JJ denotes epidermal
T19053 186-189 CC denotes and
T19052 184-185 , denotes ,
T19051 178-184 NN denotes factor
T19050 171-177 NN denotes growth
T19049 154-170 JJ denotes platelet-derived
T19048 152-153 , denotes ,
T19047 151-152 -RRB- denotes )
T19046 150-151 NNP denotes M
T19024 27-36 NNS denotes cytokines
T19023 22-26 JJ denotes many
T19022 19-21 IN denotes by
T19021 9-18 VBN denotes activated
T19020 6-8 VBZ denotes is
T19019 0-5 NNP denotes STAT3
T19045 139-149 NN denotes oncostatin
T19044 135-138 CC denotes and
T19043 133-134 , denotes ,
T19042 127-133 NN denotes factor
T19041 116-126 JJ denotes inhibitory
T19040 107-115 NN denotes leukemia
T19039 105-106 , denotes ,
T19038 100-105 NNP denotes IL-11
T19037 98-99 , denotes ,
T19036 94-98 NNP denotes IL-6
T19035 93-94 -LRB- denotes (
T19034 83-92 NNS denotes cytokines
T19033 80-82 IN denotes of
T19032 73-79 NN denotes family
T19031 68-72 NNP denotes IL-6
T19030 64-67 DT denotes the
T19029 61-63 IN denotes as
T19028 56-60 JJ denotes such
T19027 48-55 NNS denotes factors
T19026 41-47 NN denotes growth
T19025 37-40 CC denotes and
R9455 T19019 T19021 nsubjpass STAT3,activated
R9456 T19020 T19021 auxpass is,activated
R9457 T19021 T19021 ROOT activated,activated
R9458 T19022 T19021 agent by,activated
R9459 T19023 T19024 amod many,cytokines
R9460 T19024 T19022 pobj cytokines,by
R9461 T19025 T19024 cc and,cytokines
R9462 T19026 T19027 compound growth,factors
R9463 T19027 T19024 conj factors,cytokines
R9464 T19028 T19029 amod such,as
R9465 T19029 T19027 prep as,factors
R9466 T19030 T19032 det the,family
R9467 T19031 T19032 compound IL-6,family
R9468 T19032 T19029 pobj family,as
R9469 T19033 T19032 prep of,family
R9470 T19034 T19033 pobj cytokines,of
R9471 T19035 T19042 punct (,factor
R9472 T19036 T19042 nmod IL-6,factor
R9473 T19037 T19036 punct ",",IL-6
R9474 T19038 T19036 conj IL-11,IL-6
R9475 T19039 T19038 punct ",",IL-11
R9476 T19040 T19042 nmod leukemia,factor
R9477 T19041 T19042 amod inhibitory,factor
R9478 T19042 T19032 appos factor,family
R9479 T19043 T19042 punct ",",factor
R9480 T19044 T19042 cc and,factor
R9481 T19045 T19046 compound oncostatin,M
R9482 T19046 T19042 conj M,factor
R9483 T19047 T19032 punct ),family
R9484 T19048 T19051 punct ",",factor
R9485 T19049 T19051 amod platelet-derived,factor
R9486 T19050 T19051 compound growth,factor
R9487 T19051 T19027 conj factor,factors
R9488 T19052 T19051 punct ",",factor
R9489 T19053 T19051 cc and,factor
R9490 T19054 T19056 amod epidermal,factor
R9491 T19055 T19056 compound growth,factor
R9492 T19056 T19051 conj factor,factor
R9493 T19057 T19051 punct ",",factor
R9494 T19058 T19070 prep in,demonstrated
R9495 T19059 T19058 pobj addition,in
R9496 T19060 T19059 prep to,addition
R9497 T19061 T19060 pobj IL-10,to
R9498 T19062 T19064 nmod [,]
R9499 T19063 T19064 nummod 4,]
R9500 T19064 T19061 dobj ],IL-10
R9501 T19065 T19061 punct ",",IL-10
R9502 T19066 T19070 cc but,demonstrated
R9503 T19067 T19068 amod previous,studies
R9504 T19068 T19070 nsubj studies,demonstrated
R9505 T19069 T19070 aux have,demonstrated
R9506 T19070 T19021 conj demonstrated,activated
R9507 T19071 T19073 mark that,is
R9508 T19072 T19073 nsubj IL-6,is
R9509 T19073 T19070 ccomp is,demonstrated
R9510 T19074 T19076 det the,factor
R9511 T19075 T19076 amod major,factor
R9512 T19076 T19073 attr factor,is
R9513 T19077 T19076 prep in,factor
R9514 T19078 T19080 nmod RA,fluid
R9515 T19079 T19080 amod synovial,fluid
R9516 T19080 T19076 appos fluid,factor
R9517 T19081 T19082 nsubj that,induces
R9518 T19082 T19080 relcl induces,fluid
R9519 T19083 T19084 amod constitutive,activation
R9520 T19084 T19082 dobj activation,induces
R9521 T19085 T19084 prep of,activation
R9522 T19086 T19085 pobj STAT3,of
R9523 T19087 T19084 prep in,activation
R9524 T19088 T19089 amod mononuclear,cells
R9525 T19089 T19087 pobj cells,in
R9526 T19090 T19092 nmod [,]
R9527 T19091 T19092 nummod 31,]
R9528 T19092 T19080 appos ],fluid
R9529 T19093 T19070 punct .,demonstrated
R9530 T19094 T19096 mark Since,is
R9531 T19095 T19096 nsubj IL-6,is
R9532 T19096 T19107 advcl is,detected
R9533 T19097 T19096 advmod also,is
R9534 T19098 T19096 acomp abundant,is
R9535 T19099 T19098 prep in,abundant
R9536 T19100 T19099 pobj sera,in
R9537 T19101 T19100 prep of,sera
R9538 T19102 T19104 amod active,patients
R9539 T19103 T19104 compound RA,patients
R9540 T19104 T19101 pobj patients,of
R9541 T19105 T19107 punct ",",detected
R9542 T19106 T19107 advmod frequently,detected
R9543 T19107 T19117 advcl detected,examined
R9544 T19108 T19107 prep at,detected
R9545 T19109 T19108 pobj >,at
R9546 T19110 T19114 nummod 1,]
R9547 T19111 T19112 amod ng/ml,[
R9548 T19112 T19114 nmod [,]
R9549 T19113 T19114 nummod 27,]
R9550 T19114 T19107 dobj ],detected
R9551 T19115 T19117 punct ",",examined
R9552 T19116 T19117 nsubj we,examined
R9553 T19117 T19117 ROOT examined,examined
R9554 T19118 T19135 mark whether,was
R9555 T19119 T19120 amod persistent,exposure
R9556 T19120 T19135 nsubj exposure,was
R9557 T19121 T19120 prep of,exposure
R9558 T19122 T19125 nummod CD4,cells
R9559 T19123 T19125 nummod +,cells
R9560 T19124 T19125 compound T,cells
R9561 T19125 T19121 pobj cells,of
R9562 T19126 T19120 prep to,exposure
R9563 T19127 T19128 amod high,concentrations
R9564 T19128 T19126 pobj concentrations,to
R9565 T19129 T19128 prep of,concentrations
R9566 T19130 T19129 pobj IL-6,of
R9567 T19131 T19128 prep in,concentrations
R9568 T19132 T19134 det the,circulation
R9569 T19133 T19134 compound blood,circulation
R9570 T19134 T19131 pobj circulation,in
R9571 T19135 T19117 ccomp was,examined
R9572 T19136 T19135 acomp responsible,was
R9573 T19137 T19136 prep for,responsible
R9574 T19138 T19141 poss their,activation
R9575 T19139 T19141 amod sustained,activation
R9576 T19140 T19141 nummod STAT3,activation
R9577 T19141 T19137 pobj activation,for
R9578 T19142 T19141 cc and,activation
R9579 T19143 T19141 conj resistance,activation
R9580 T19144 T19143 prep to,resistance
R9581 T19145 T19146 compound IL-10,inhibition
R9582 T19146 T19144 pobj inhibition,to
R9583 T19147 T19146 prep in,inhibition
R9584 T19148 T19149 amod active,RA
R9585 T19149 T19147 pobj RA,in
R9586 T19150 T19117 punct .,examined
R9587 T19151 T19152 det Both,STAT1
R9588 T19152 T19155 nummod STAT1,phosphorylation
R9589 T19153 T19152 cc and,STAT1
R9590 T19154 T19152 conj STAT3,STAT1
R9591 T19155 T19157 nsubjpass phosphorylation,activated
R9592 T19156 T19157 auxpass was,activated
R9593 T19157 T19157 ROOT activated,activated
R9594 T19158 T19157 agent by,activated
R9595 T19159 T19158 pobj IL-6,by
R9596 T19160 T19157 prep in,activated
R9597 T19161 T19165 amod normal,cells
R9598 T19162 T19165 nmod CD4,cells
R9599 T19163 T19165 nummod +,cells
R9600 T19164 T19165 compound T,cells
R9601 T19165 T19160 pobj cells,in
R9602 T19166 T19165 punct (,cells
R9603 T19167 T19177 nsubj data,[
R9604 T19168 T19169 neg not,shown
R9605 T19169 T19167 acl shown,data
R9606 T19170 T19167 punct ),data
R9607 T19171 T19177 punct ",",[
R9608 T19172 T19177 prep in,[
R9609 T19173 T19172 pobj agreement,in
R9610 T19174 T19173 prep with,agreement
R9611 T19175 T19176 amod previous,observations
R9612 T19176 T19174 pobj observations,with
R9613 T19177 T19157 advcl [,activated
R9614 T19178 T19179 nummod 4,]
R9615 T19179 T19177 dobj ],[
R9616 T19180 T19177 punct .,[
R9617 T19181 T19185 amod Normal,cells
R9618 T19182 T19185 compound CD4,cells
R9619 T19183 T19185 nummod +,cells
R9620 T19184 T19185 compound T,cells
R9621 T19185 T19188 nsubjpass cells,incubated
R9622 T19186 T19188 auxpass were,incubated
R9623 T19187 T19188 advmod thus,incubated
R9624 T19188 T19188 ROOT incubated,incubated
R9625 T19189 T19188 prep for,incubated
R9626 T19190 T19191 nummod 20,min
R9627 T19191 T19189 pobj min,for
R9628 T19192 T19191 prep with,min
R9629 T19193 T19194 compound culture,medium
R9630 T19194 T19195 nsubj medium,containing
R9631 T19195 T19192 pcomp containing,with
R9632 T19196 T19197 nummod 30,%
R9633 T19197 T19198 compound %,serum
R9634 T19198 T19195 dobj serum,containing
R9635 T19199 T19198 prep from,serum
R9636 T19200 T19202 amod active,patients
R9637 T19201 T19202 compound RA,patients
R9638 T19202 T19199 pobj patients,from
R9639 T19203 T19195 cc and,containing
R9640 T19204 T19195 conj neutralizing,containing
R9641 T19205 T19206 amod anti-IL-6,antibody
R9642 T19206 T19204 dobj antibody,neutralizing
R9643 T19207 T19206 cc or,antibody
R9644 T19208 T19209 compound control,antibody
R9645 T19209 T19206 conj antibody,antibody
R9646 T19210 T19204 punct ",",neutralizing
R9647 T19211 T19204 cc and,neutralizing
R9648 T19212 T19213 compound STAT,phosphorylation
R9649 T19213 T19215 nsubjpass phosphorylation,examined
R9650 T19214 T19215 auxpass was,examined
R9651 T19215 T19188 advcl examined,incubated
R9652 T19216 T19215 agent by,examined
R9653 T19217 T19219 amod western,analysis
R9654 T19218 T19219 compound blot,analysis
R9655 T19219 T19216 pobj analysis,by
R9656 T19220 T19215 punct .,examined
R9657 T19221 T19222 compound RA,serum
R9658 T19222 T19223 nsubj serum,was
R9659 T19223 T19223 ROOT was,was
R9660 T19224 T19223 acomp able,was
R9661 T19225 T19226 aux to,induce
R9662 T19226 T19224 xcomp induce,able
R9663 T19227 T19228 amod tyrosine,phosphorylation
R9664 T19228 T19226 dobj phosphorylation,induce
R9665 T19229 T19228 prep of,phosphorylation
R9666 T19230 T19229 pobj STAT3,of
R9667 T19231 T19230 cc but,STAT3
R9668 T19232 T19233 neg not,STAT1
R9669 T19233 T19241 nsubjpass STAT1,abolished
R9670 T19234 T19233 punct ",",STAT1
R9671 T19235 T19233 cc and,STAT1
R9672 T19236 T19238 det this,activation
R9673 T19237 T19238 nummod STAT3,activation
R9674 T19238 T19233 conj activation,STAT1
R9675 T19239 T19241 auxpass was,abolished
R9676 T19240 T19241 advmod mostly,abolished
R9677 T19241 T19223 advcl abolished,was
R9678 T19242 T19241 agent by,abolished
R9679 T19243 T19242 pobj neutralization,by
R9680 T19244 T19243 prep of,neutralization
R9681 T19245 T19246 compound IL-6,activity
R9682 T19246 T19244 pobj activity,of
R9683 T19247 T19241 punct (,abolished
R9684 T19248 T19249 compound Fig.,5a
R9685 T19249 T19241 npadvmod 5a,abolished
R9686 T19250 T19241 punct ),abolished
R9687 T19251 T19223 punct .,was
R9688 T19252 T19253 det These,results
R9689 T19253 T19254 nsubj results,indicate
R9690 T19254 T19254 ROOT indicate,indicate
R9691 T19255 T19257 mark that,is
R9692 T19256 T19257 nsubj IL-6,is
R9693 T19257 T19254 ccomp is,indicate
R9694 T19258 T19261 det the,factor
R9695 T19259 T19261 amod dominant,factor
R9696 T19260 T19261 amod STAT3-activating,factor
R9697 T19261 T19257 attr factor,is
R9698 T19262 T19261 acl contained,factor
R9699 T19263 T19262 prep in,contained
R9700 T19264 T19263 pobj sera,in
R9701 T19265 T19264 prep of,sera
R9702 T19266 T19268 amod active,patients
R9703 T19267 T19268 compound RA,patients
R9704 T19268 T19265 pobj patients,of
R9705 T19269 T19254 punct .,indicate
R9706 T19270 T19271 det The,lack
R9707 T19271 T19278 nsubj lack,suggests
R9708 T19272 T19271 prep of,lack
R9709 T19273 T19274 nummod STAT1,activation
R9710 T19274 T19272 pobj activation,of
R9711 T19275 T19274 prep by,activation
R9712 T19276 T19277 compound RA,serum
R9713 T19277 T19275 pobj serum,by
R9714 T19278 T19278 ROOT suggests,suggests
R9715 T19279 T19287 mark that,required
R9716 T19280 T19281 advmod much,higher
R9717 T19281 T19282 amod higher,concentrations
R9718 T19282 T19287 nsubjpass concentrations,required
R9719 T19283 T19282 prep of,concentrations
R9720 T19284 T19283 pobj IL-6,of
R9721 T19285 T19287 aux may,required
R9722 T19286 T19287 auxpass be,required
R9723 T19287 T19278 ccomp required,suggests
R9724 T19288 T19287 prep for,required
R9725 T19289 T19290 nummod STAT1,activation
R9726 T19290 T19288 pobj activation,for
R9727 T19291 T19290 prep as,activation
R9728 T19292 T19291 prep compared,as
R9729 T19293 T19292 prep with,compared
R9730 T19294 T19295 nummod STAT3,activation
R9731 T19295 T19293 pobj activation,with
R9732 T19296 T19295 punct ",",activation
R9733 T19297 T19295 cc or,activation
R9734 T19298 T19304 mark that,be
R9735 T19299 T19304 nsubj inhibitors,be
R9736 T19300 T19299 prep of,inhibitors
R9737 T19301 T19300 pobj STAT1,of
R9738 T19302 T19304 nsubj signaling,be
R9739 T19303 T19304 aux may,be
R9740 T19304 T19287 advcl be,required
R9741 T19305 T19304 acomp present,be
R9742 T19306 T19305 prep in,present
R9743 T19307 T19308 compound RA,serum
R9744 T19308 T19306 pobj serum,in
R9745 T19309 T19278 punct .,suggests

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T18352 1119-1125 Positive_regulation denotes induce
T18351 1119-1125 Positive_regulation denotes induce
T18350 1225-1239 Negative_regulation denotes neutralization
T18349 1225-1239 Negative_regulation denotes neutralization
T18348 1190-1200 Positive_regulation denotes activation
T18347 1135-1150 Phosphorylation denotes phosphorylation
T18346 1135-1150 Phosphorylation denotes phosphorylation
T18345 1126-1134 Entity denotes tyrosine
T18344 1258-1265 Protein denotes Fig. 5a
T18343 1243-1247 Protein denotes IL-6
T18342 1184-1189 Protein denotes STAT3
T18341 1168-1173 Protein denotes STAT1
T18340 1154-1159 Protein denotes STAT3
T18339 1043-1058 Phosphorylation denotes phosphorylation
T18338 981-993 Positive_regulation denotes neutralizing
T18337 1038-1042 Protein denotes STAT
T18336 994-1032 Protein denotes anti-IL-6 antibody or control antibody
T18335 868-871 Protein denotes CD4
T18334 757-766 Positive_regulation denotes activated
T18333 757-766 Positive_regulation denotes activated
T18332 757-766 Positive_regulation denotes activated
T18331 757-766 Positive_regulation denotes activated
T18330 737-752 Phosphorylation denotes phosphorylation
T18329 737-752 Phosphorylation denotes phosphorylation
T18328 785-789 Protein denotes CD4+
T18327 770-774 Protein denotes IL-6
T18326 731-736 Protein denotes STAT3
T18325 721-726 Protein denotes STAT1
T18324 618-629 Positive_regulation denotes responsible
T18323 691-701 Negative_regulation denotes inhibition
T18322 656-666 Positive_regulation denotes activation
T18321 566-580 Positive_regulation denotes concentrations
T18320 685-690 Protein denotes IL-10
T18319 650-655 Protein denotes STAT3
T18318 584-588 Protein denotes IL-6
T18317 545-549 Protein denotes CD4+
T18316 410-414 Protein denotes IL-6
T18315 336-343 Positive_regulation denotes induces
T18314 357-367 Positive_regulation denotes activation
T18313 9-18 Positive_regulation denotes activated
T18312 371-376 Protein denotes STAT3
T18311 285-289 Protein denotes IL-6
T18310 139-151 Protein denotes oncostatin M
T18309 100-105 Protein denotes IL-11
T18308 0-5 Protein denotes STAT3
T18369 1479-1487 Positive_regulation denotes required
T18368 1386-1390 Negative_regulation denotes lack
T18367 1589-1596 Positive_regulation denotes present
T18366 1552-1562 Negative_regulation denotes inhibitors
T18365 1532-1542 Positive_regulation denotes activation
T18364 1498-1508 Positive_regulation denotes activation
T18363 1449-1463 Positive_regulation denotes concentrations
T18362 1400-1410 Positive_regulation denotes activation
T18361 1566-1571 Protein denotes STAT1
T18360 1526-1531 Protein denotes STAT3
T18359 1492-1497 Protein denotes STAT1
T18358 1467-1471 Protein denotes IL-6
T18357 1394-1399 Protein denotes STAT1
T18356 1308-1340 Protein denotes dominant STAT3-activating factor
T18355 1296-1300 Protein denotes IL-6
T18354 1212-1221 Negative_regulation denotes abolished
T18353 1212-1221 Negative_regulation denotes abolished
R8948 T18357 T18362 themeOf STAT1,activation
R8949 T18358 T18363 themeOf IL-6,concentrations
R8950 T18359 T18364 themeOf STAT1,activation
R8951 T18360 T18365 themeOf STAT3,activation
R8952 T18361 T18366 themeOf STAT1,inhibitors
R8953 T18362 T18368 themeOf activation,lack
R8954 T18364 T18369 themeOf activation,required
R8955 T18366 T18367 themeOf inhibitors,present
R8914 T18308 T18313 themeOf STAT3,activated
R8915 T18312 T18314 themeOf STAT3,activation
R8916 T18314 T18315 themeOf activation,induces
R8917 T18318 T18321 themeOf IL-6,concentrations
R8918 T18319 T18322 themeOf STAT3,activation
R8919 T18320 T18323 themeOf IL-10,inhibition
R8920 T18322 T18324 themeOf activation,responsible
R8921 T18325 T18329 themeOf STAT1,phosphorylation
R8923 T18326 T18330 themeOf STAT3,phosphorylation
R8925 T18327 T18331 causeOf IL-6,activated
R8922 T18325 T18331 themeOf STAT1,activated
R8924 T18326 T18332 themeOf STAT3,activated
R8926 T18327 T18332 causeOf IL-6,activated
R8927 T18327 T18333 causeOf IL-6,activated
R8928 T18327 T18334 causeOf IL-6,activated
R8929 T18329 T18333 themeOf phosphorylation,activated
R8930 T18330 T18334 themeOf phosphorylation,activated
R8931 T18336 T18338 themeOf anti-IL-6 antibody or control antibody,neutralizing
R8932 T18337 T18339 themeOf STAT,phosphorylation
R8933 T18340 T18346 themeOf STAT3,phosphorylation
R8934 T18340 T18345 partOf STAT3,tyrosine
R8935 T18341 T18347 themeOf STAT1,phosphorylation
R8936 T18341 T18345 partOf STAT1,tyrosine
R8937 T18342 T18348 themeOf STAT3,activation
R8938 T18343 T18349 themeOf IL-6,neutralization
R8939 T18344 T18350 themeOf Fig. 5a,neutralization
R8940 T18345 T18346 Site tyrosine,phosphorylation
R8941 T18345 T18347 Site tyrosine,phosphorylation
R8942 T18346 T18351 themeOf phosphorylation,induce
R8943 T18347 T18352 themeOf phosphorylation,induce
R8944 T18348 T18353 themeOf activation,abolished
R8945 T18348 T18354 themeOf activation,abolished
R8946 T18349 T18353 causeOf neutralization,abolished
R8947 T18350 T18354 causeOf neutralization,abolished

test3

Id Subject Object Predicate Lexical cue
T17424 1566-1571 Protein denotes STAT1
T17423 1552-1562 Negative_regulation denotes inhibitors
T17422 1532-1542 Positive_regulation denotes activation
T17421 1526-1531 Protein denotes STAT3
T17420 1498-1508 Positive_regulation denotes activation
T17419 1492-1497 Protein denotes STAT1
T17418 1479-1487 Positive_regulation denotes required
T17417 1467-1471 Protein denotes IL-6
T17416 1400-1410 Positive_regulation denotes activation
T17415 1394-1399 Protein denotes STAT1
T17414 1386-1390 Negative_regulation denotes lack
T17413 1317-1322 Protein denotes STAT3
T17412 1296-1300 Protein denotes IL-6
T17411 1243-1247 Protein denotes IL-6
T17410 1225-1239 Negative_regulation denotes neutralization
T17409 1212-1221 Negative_regulation denotes abolished
T17408 1190-1200 Positive_regulation denotes activation
T17407 1184-1189 Protein denotes STAT3
T17406 1168-1173 Protein denotes STAT1
T17405 1154-1159 Protein denotes STAT3
T17404 1135-1150 Phosphorylation denotes phosphorylation
T17403 1119-1125 Positive_regulation denotes induce
T17402 1043-1058 Phosphorylation denotes phosphorylation
T17401 999-1003 Protein denotes IL-6
T17400 868-871 Protein denotes CD4
T17399 785-788 Protein denotes CD4
T17398 770-774 Protein denotes IL-6
T17397 757-766 Positive_regulation denotes activated
T17396 737-752 Phosphorylation denotes phosphorylation
T17395 731-736 Protein denotes STAT3
T17394 721-726 Protein denotes STAT1
T17393 691-701 Negative_regulation denotes inhibition
T17392 685-690 Protein denotes IL-10
T17391 656-666 Positive_regulation denotes activation
T17390 650-655 Protein denotes STAT3
T17389 584-588 Protein denotes IL-6
T17388 545-548 Protein denotes CD4
T17387 410-414 Protein denotes IL-6
T17386 371-376 Protein denotes STAT3
T17385 357-367 Positive_regulation denotes activation
T17384 336-343 Positive_regulation denotes induces
T17383 285-289 Protein denotes IL-6
T17382 230-235 Protein denotes IL-10
T17381 190-213 Protein denotes epidermal growth factor
T17380 154-184 Protein denotes platelet-derived growth factor
T17379 139-151 Protein denotes oncostatin M
T17378 107-133 Protein denotes leukemia inhibitory factor
T17377 100-105 Protein denotes IL-11
T17376 94-98 Protein denotes IL-6
T17375 9-18 Positive_regulation denotes activated
T17374 0-5 Protein denotes STAT3
T17347 1566-1571 Protein denotes STAT1
T17346 1526-1531 Protein denotes STAT3
T17345 1492-1497 Protein denotes STAT1
T17344 1467-1471 Protein denotes IL-6
T17343 1394-1399 Protein denotes STAT1
T17342 1317-1322 Protein denotes STAT3
T17341 1296-1300 Protein denotes IL-6
T17340 1243-1247 Protein denotes IL-6
T17339 1184-1189 Protein denotes STAT3
T17338 1168-1173 Protein denotes STAT1
T17337 1154-1159 Protein denotes STAT3
T17336 999-1003 Protein denotes IL-6
T17335 868-871 Protein denotes CD4
T17334 785-788 Protein denotes CD4
T17333 770-774 Protein denotes IL-6
T17332 731-736 Protein denotes STAT3
T17331 721-726 Protein denotes STAT1
T17330 685-690 Protein denotes IL-10
T17329 650-655 Protein denotes STAT3
T17328 584-588 Protein denotes IL-6
T17327 545-548 Protein denotes CD4
T17326 410-414 Protein denotes IL-6
T17325 371-376 Protein denotes STAT3
T17324 285-289 Protein denotes IL-6
T17323 230-235 Protein denotes IL-10
T17322 190-213 Protein denotes epidermal growth factor
T17321 154-184 Protein denotes platelet-derived growth factor
T17320 139-151 Protein denotes oncostatin M
T17319 107-133 Protein denotes leukemia inhibitory factor
T17318 100-105 Protein denotes IL-11
T17317 94-98 Protein denotes IL-6
T17316 0-5 Protein denotes STAT3
R8781 T17374 T17375 themeOf STAT3,activated
R8782 T17377 T17375 causeOf IL-11,activated
R8783 T17378 T17375 causeOf leukemia inhibitory factor,activated
R8784 T17379 T17375 causeOf oncostatin M,activated
R8785 T17379 T17384 causeOf oncostatin M,induces
R8786 T17380 T17375 causeOf platelet-derived growth factor,activated
R8787 T17381 T17384 causeOf epidermal growth factor,induces
R8788 T17381 T17375 causeOf epidermal growth factor,activated
R8789 T17382 T17375 causeOf IL-10,activated
R8790 T17383 T17384 causeOf IL-6,induces
R8791 T17385 T17384 themeOf activation,induces
R8792 T17386 T17385 themeOf STAT3,activation
R8793 T17390 T17391 themeOf STAT3,activation
R8794 T17392 T17393 themeOf IL-10,inhibition
R8795 T17394 T17396 themeOf STAT1,phosphorylation
R8796 T17395 T17396 themeOf STAT3,phosphorylation
R8797 T17396 T17397 themeOf phosphorylation,activated
R8798 T17398 T17397 causeOf IL-6,activated
R8799 T17403 T17409 themeOf induce,abolished
R8800 T17404 T17403 themeOf phosphorylation,induce
R8801 T17404 T17409 themeOf phosphorylation,abolished
R8802 T17405 T17404 themeOf STAT3,phosphorylation
R8803 T17406 T17404 themeOf STAT1,phosphorylation
R8804 T17407 T17408 themeOf STAT3,activation
R8805 T17408 T17409 themeOf activation,abolished
R8806 T17410 T17409 causeOf neutralization,abolished
R8807 T17411 T17410 themeOf IL-6,neutralization
R8808 T17415 T17416 themeOf STAT1,activation
R8809 T17416 T17414 themeOf activation,lack
R8810 T17419 T17420 themeOf STAT1,activation
R8811 T17420 T17418 themeOf activation,required
R8812 T17421 T17422 themeOf STAT3,activation
R8813 T17422 T17418 themeOf activation,required

testone

Id Subject Object Predicate Lexical cue
T17252 1532-1542 Positive_regulation denotes activation
T17251 1479-1487 Positive_regulation denotes required
T17250 1225-1239 Negative_regulation denotes neutralization
T17249 1212-1221 Negative_regulation denotes abolished
T17248 1190-1200 Positive_regulation denotes activation
T17247 1135-1150 Phosphorylation denotes phosphorylation
T17246 1119-1125 Positive_regulation denotes induce
T17245 1043-1058 Phosphorylation denotes phosphorylation
T17244 757-766 Positive_regulation denotes activated
T17243 737-752 Phosphorylation denotes phosphorylation
T17242 691-701 Negative_regulation denotes inhibition
T17241 656-666 Positive_regulation denotes activation
T17240 618-629 Positive_regulation denotes responsible
T17239 357-367 Positive_regulation denotes activation
T17238 336-343 Positive_regulation denotes induces
T17237 9-18 Positive_regulation denotes activated
T17214 1566-1571 Protein denotes STAT1
T17213 1526-1531 Protein denotes STAT3
T17212 1492-1497 Protein denotes STAT1
T17211 1467-1471 Protein denotes IL-6
T17210 1394-1399 Protein denotes STAT1
T17209 1317-1322 Protein denotes STAT3
T17208 1296-1300 Protein denotes IL-6
T17207 1243-1247 Protein denotes IL-6
T17206 1184-1189 Protein denotes STAT3
T17205 1168-1173 Protein denotes STAT1
T17204 1154-1159 Protein denotes STAT3
T17203 999-1003 Protein denotes IL-6
T17202 868-871 Protein denotes CD4
T17201 785-788 Protein denotes CD4
T17200 770-774 Protein denotes IL-6
T17199 731-736 Protein denotes STAT3
T17198 721-726 Protein denotes STAT1
T17197 685-690 Protein denotes IL-10
T17196 650-655 Protein denotes STAT3
T17195 584-588 Protein denotes IL-6
T17194 545-548 Protein denotes CD4
T17193 410-414 Protein denotes IL-6
T17192 371-376 Protein denotes STAT3
T17191 285-289 Protein denotes IL-6
T17190 230-235 Protein denotes IL-10
T17189 190-213 Protein denotes epidermal growth factor
T17188 154-184 Protein denotes platelet-derived growth factor
T17187 139-151 Protein denotes oncostatin M
T17186 107-133 Protein denotes leukemia inhibitory factor
T17185 100-105 Protein denotes IL-11
T17184 94-98 Protein denotes IL-6
T17183 0-5 Protein denotes STAT3
R8729 T17183 T17237 themeOf STAT3,activated
R8730 T17185 T17237 causeOf IL-11,activated
R8731 T17186 T17237 causeOf leukemia inhibitory factor,activated
R8732 T17187 T17237 causeOf oncostatin M,activated
R8733 T17188 T17237 causeOf platelet-derived growth factor,activated
R8734 T17189 T17238 causeOf epidermal growth factor,induces
R8735 T17189 T17237 causeOf epidermal growth factor,activated
R8736 T17190 T17237 causeOf IL-10,activated
R8737 T17191 T17238 causeOf IL-6,induces
R8738 T17191 T17237 causeOf IL-6,activated
R8739 T17192 T17239 themeOf STAT3,activation
R8740 T17196 T17241 themeOf STAT3,activation
R8741 T17197 T17242 themeOf IL-10,inhibition
R8742 T17198 T17243 themeOf STAT1,phosphorylation
R8743 T17199 T17243 themeOf STAT3,phosphorylation
R8744 T17200 T17244 causeOf IL-6,activated
R8745 T17204 T17247 themeOf STAT3,phosphorylation
R8746 T17205 T17247 themeOf STAT1,phosphorylation
R8747 T17206 T17248 themeOf STAT3,activation
R8748 T17207 T17250 themeOf IL-6,neutralization
R8749 T17213 T17252 themeOf STAT3,activation
R8761 T17239 T17238 themeOf activation,induces
R8762 T17241 T17240 themeOf activation,responsible
R8763 T17242 T17240 themeOf inhibition,responsible
R8764 T17243 T17244 themeOf phosphorylation,activated
R8765 T17246 T17249 themeOf induce,abolished
R8766 T17247 T17246 themeOf phosphorylation,induce
R8767 T17248 T17249 themeOf activation,abolished
R8768 T17250 T17249 causeOf neutralization,abolished
R8769 T17252 T17251 themeOf activation,required